<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fphar.2017.00653</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Induction of Mkp-1 and Nuclear Translocation of Nrf2 by Limonoids from <italic>Khaya grandifoliola</italic> C.DC Protect L-02 Hepatocytes against Acetaminophen-Induced Hepatotoxicity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kouam</surname> <given-names>Arnaud F.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/452291/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yuan</surname> <given-names>Fei</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/475464/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Njayou</surname> <given-names>Fr&#x00E9;d&#x00E9;ric N.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/225470/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>He</surname> <given-names>Hongtao</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/475371/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Tsayem</surname> <given-names>Rom&#x00E9;o F.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/475398/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Oladejo</surname> <given-names>Babayemi O.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/463721/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Song</surname> <given-names>Fuhang</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/424830/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Moundipa</surname> <given-names>Paul F.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/222386/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Gao</surname> <given-names>George F.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/236190/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratory of Pharmacology and Toxicology, Department of Biochemistry, Faculty of Science, University of Yaound&#x00E9; 1</institution> <country>Yaound&#x00E9;, Cameroon</country></aff>
<aff id="aff2"><sup>2</sup><institution>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences</institution> <country>Beijing, China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: <italic>Banasri Hazra, Jadavpur University, India</italic></p></fn>
<fn fn-type="edited-by"><p>Reviewed by: <italic>SubbaRao V. Madhunapantula, Jagadguru Sri Shivarathreeswara University, India; Germain Sotoing Taiwe, University of Buea, Cameroon</italic></p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x002A;Correspondence: <italic>Paul F. Moundipa, <email>pmoundipa@hotmail.com</email>; <email>pmoundipa@uy1.uninet.cm</email></italic></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>09</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>653</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>06</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>09</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017 Kouam, Yuan, Njayou, He, Tsayem, Oladejo, Song, Moundipa and Gao.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Kouam, Yuan, Njayou, He, Tsayem, Oladejo, Song, Moundipa and Gao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Drug-induced liver injury (DILI) is a major clinical problem where natural compounds hold promise for its abrogation. <italic>Khaya grandifoliola</italic> (Meliaceae) is used in Cameroonian traditional medicine for the treatment of liver related diseases and has been studied for its hepatoprotective properties. Till date, reports showing the hepatoprotective molecular mechanism of the plant are lacking. The aim of this study was therefore to identify compounds from the plant bearing hepatoprotective activity and the related molecular mechanism by assessing their effects against acetaminophen (APAP)-induced hepatotoxicity in normal human liver L-02 cells line. The cells were exposed to APAP (10 mM) or co-treated with phytochemical compounds (40 &#x03BC;M) over a period of 36 h and, biochemical and molecular parameters assessed. Three known limonoids namely 17-epi-methyl-6-hydroxylangolensate, 7-deacetoxy-7-oxogedunin and deacetoxy-7R-hydroxygedunin were identified. The results of cells viability and membrane integrity, reactive oxygen species generation and lipid membrane peroxidation assays, cellular glutathione content determination as well as expression of cytochrome P450 2E1 demonstrated the protective action of the limonoids. Immunoblotting analysis revealed that limonoids inhibited APAP-induced c-Jun N-terminal Kinase phosphorylation (p-JNK), mitochondrial translocation of p-JNK and Bcl<sub>2</sub>-associated X Protein, and the release of Apoptosis-inducing Factor into the cytosol. Interestingly, limonoids increased the expression of Mitogen-activated Protein Kinase Phosphatase (Mkp)-1, an endogenous inhibitor of JNK phosphorylation and, induced the nuclear translocation of Nuclear Factor Erythroid 2-related Factor-2 (Nrf2) and decreased the expression of Kelch-like ECH-associated Protein-1. The limonoids also reversed the APAP-induced decreased mRNA levels of Catalase, Superoxide Dismutase-1, Glutathione-<italic>S</italic>-Transferase and Methionine Adenosyltransferase-1A. The obtained results suggest that the isolated limonoids protect L-02 hepatocytes against APAP-induced hepatotoxicity mainly through increase expression of Mkp-1 and nuclear translocation of Nrf2. Thus, these compounds are in part responsible of the hepatoprotective activity of <italic>K. grandifoliola</italic> and further analysis including <italic>in vivo</italic> and toxicological studies are needed to select the most potent compound that may be useful as therapeutic agents against DILI.</p>
</abstract>
<kwd-group>
<kwd><italic>K. grandifoliola</italic></kwd>
<kwd>limonoids</kwd>
<kwd>acetaminophen</kwd>
<kwd>hepatoprotection</kwd>
<kwd>Mkp-1</kwd>
<kwd>Nrf2</kwd>
</kwd-group>
<contract-num rid="cn001">S/CMR15-06</contract-num>
<contract-sponsor id="cn001">International Center for Genetic Engineering and Biotechnology<named-content content-type="fundref-id">10.13039/100007675</named-content></contract-sponsor>
<counts>
<fig-count count="13"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="60"/>
<page-count count="18"/>
<word-count count="0"/>
</counts>
</article-meta>
</front>
<body>
<sec><title>Introduction</title>
<p>Liver is the main site of detoxification and as such, represents the primary target of drug exposure in the body (<xref ref-type="bibr" rid="B32">Kumari and Kakkar</xref>, <xref ref-type="bibr" rid="B32">2012a</xref>). DILI is a major clinical problem and public concern worldwide (<xref ref-type="bibr" rid="B25">Jaeschke et al., 2014</xref>). It is the case of APAP (<italic>N</italic>-acetyl-para-amino-phenol), a commonly used analgesic and antipyretic drug that is safe at therapeutic dose; but can cause severe hepatotoxicity and even death at an overdose (<xref ref-type="bibr" rid="B43">Nourjah et al., 2006</xref>). APAP-hepatotoxicity cannot only bind to its biotransformation, essentially by the isoform 2E1 of cytochrome P450 enzymes to form a reactive metabolite; <italic>N</italic>-acetyl-para benzo-quinone imine (NAPQI), but also to the excessive generation of ROS. Overproductions of NAPQI and ROS cause a depletion of glutathione (GSH) as well as the inactivation of antioxidant enzymes, leading to oxidative stress (<xref ref-type="bibr" rid="B25">Jaeschke et al., 2014</xref>). Additionally, NAPQI and ROS if excessive can covalently bind and/or oxidize cellular macromolecules, causing hepatocytes death and liver injury (<xref ref-type="bibr" rid="B59">Xie et al., 2014</xref>). Furthermore, several studies have recently demonstrated that oxidant stress activates specific downstream biochemical signaling cascades, which perpetuate APAP-induced hepatotoxicity; including the c-Junc N-terminal kinase (JNK) family (<xref ref-type="bibr" rid="B16">Gunawan et al., 2006</xref>; <xref ref-type="bibr" rid="B49">Saito et al., 2010</xref>; <xref ref-type="bibr" rid="B59">Xie et al., 2014</xref>).</p>
<p>Junc N-terminal kinase proteins are members of the MAPK superfamily that regulate numerous cellular processes and diseases, including liver injury and hepatocytes death (<xref ref-type="bibr" rid="B51">Singh et al., 2009</xref>; <xref ref-type="bibr" rid="B49">Saito et al., 2010</xref>). Oxidant stress generated during APAP-hepatotoxicity leads to the JNK activation, likely by the upstream kinases, including apoptosis signal-regulating kinases (<xref ref-type="bibr" rid="B38">Nakagawa et al., 2008</xref>). Activated JNK amplifies hepatic damages by altering redox status, modulating Bcl-2 protein family activity, and inducing mitochondrial dysfunction (<xref ref-type="bibr" rid="B3">Bajt et al., 2006</xref>, <xref ref-type="bibr" rid="B4">2008</xref>, <xref ref-type="bibr" rid="B5">2011</xref>; <xref ref-type="bibr" rid="B49">Saito et al., 2010</xref>). Since oxidative stress and JNK activation are emerging as key mediators in APAP-induced liver injury, recent studies have examined up-regulation of antioxidative pathways and endogenous or exogenous JNK inhibitors for their potential therapeutic use (<xref ref-type="bibr" rid="B49">Saito et al., 2010</xref>; <xref ref-type="bibr" rid="B56">Wancket et al., 2012</xref>; <xref ref-type="bibr" rid="B47">Pang et al., 2016</xref>). One such class of endogenous JNK inhibitors is the MAPK phosphatase-1 (Mkp-1) (<xref ref-type="bibr" rid="B30">Keyse, 2000</xref>; <xref ref-type="bibr" rid="B57">Wang and Liu, 2007</xref>) while the nuclear factor-erythroid 2(NF-E2) related factor-2 (Nrf2) signaling is an example of antioxidative pathways (<xref ref-type="bibr" rid="B39">Niture et al., 2010</xref>).</p>
<p>Mkp-1, also referred as DUSP-1 (dual specificity protein phosphatase-1) is the prototype of the Mkp family which preferentially inactivated the stress-induced by MAPK JNK proteins in mammalian cells (<xref ref-type="bibr" rid="B17">Hammer et al., 2006</xref>). <xref ref-type="bibr" rid="B29">Kamata et al. (2005)</xref> demonstrated that ROS promotes sustained JNK activation and cell death by inhibiting Mkp-1. Moreover, Mkp-1 deficiency enhances APAP hepatotoxicity by prolonging hepatic JNK activation (<xref ref-type="bibr" rid="B56">Wancket et al., 2012</xref>). These data provide indications that Mkp-1 maybe a novel endogenous hepatoprotective factor during hepatotoxicity.</p>
<p>Up-regulation of many antioxidant enzymes in the liver is mediated by Nrf2, a transcription factor which plays a pivotal role in the activation of antioxidant gene expression (<xref ref-type="bibr" rid="B39">Niture et al., 2010</xref>). Upon cell stimulation, Nrf2 dissociates from its suppressor, Keap-1 and translocates into the nucleus where it binds to the antioxidant response elements (ARE) and promotes the expression of its target genes such as superoxide dismutase (SOD), CAT and glutathione <italic>S</italic>-transferase (GST) (<xref ref-type="bibr" rid="B26">Jaiswal, 2004</xref>). It has been shown that Nrf2 protects liver against several xenobiotic through transcriptional up-regulation of antioxidant enzymes (<xref ref-type="bibr" rid="B11">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="B47">Pang et al., 2016</xref>), suggesting that activation of Keap1-Nrf2 pathway may also be a novel strategy to prevent DILI.</p>
<p>Several herbal medicines and their active constituents have been shown to protect liver against the aforementioned pathological processes (<xref ref-type="bibr" rid="B35">Madrigal-Santill&#x00E1;n et al., 2014</xref>). It is the case of <italic>Khaya grandifoliola</italic>, a plant belonging to the family of Meliaceae, widely distributed from western Africa to Guinean coast. In Cameroon, <italic>K. grandifoliola</italic> is used in traditional medicine for the treatment of jaundice and others related liver diseases (<xref ref-type="bibr" rid="B37">Moundipa et al., 2002</xref>). Ethnobotanical surveys conducted in Nigeria also reported that the plant is used in folk medicine for the treatment of malaria, anemia, arthritis, convulsion and fever (<xref ref-type="bibr" rid="B44">Odugbemi et al., 2007</xref>; <xref ref-type="bibr" rid="B45">Olowokudejo et al., 2008</xref>). Pharmacological studies on this plant have demonstrated anti-malarial (<xref ref-type="bibr" rid="B36">Makinde et al., 2006</xref>), antibacterial (<xref ref-type="bibr" rid="B52">Stephen et al., 2009</xref>), anti-anemic (<xref ref-type="bibr" rid="B1">Adeyemi and Gbilade, 2006</xref>), anti-inflammatory (<xref ref-type="bibr" rid="B14">Falodun et al., 2009</xref>) and antifungal (<xref ref-type="bibr" rid="B46">Onifade, 2006</xref>) activities. Phytochemical studies have led to the isolation and characterization of 11 limonoids including grandifotane A (<xref ref-type="bibr" rid="B60">Yuan et al., 2010</xref>), methylangolensate and gedunin which showed anti-plasmodial effects (<xref ref-type="bibr" rid="B6">Bickii et al., 2000</xref>; <xref ref-type="bibr" rid="B36">Makinde et al., 2006</xref>). In addition, its hepatoprotective properties have been demonstrated and, a fraction with highly promising activity has been isolated (<xref ref-type="bibr" rid="B41">Njayou et al., 2013</xref>, <xref ref-type="bibr" rid="B40">2015</xref>, <xref ref-type="bibr" rid="B42">2016</xref>). However, there are no available reports showing the hepatoprotective molecular mechanism of its active ingredients. Taking into account the complex pathophysiology of APAP-induced hepatotoxicity, this study was designed to investigate the protective mechanism of active compounds isolated from <italic>K. grandifoliola</italic> in APAP-induced oxidative damage in L-02 cell, a hepatocyte cell line, by assessing their effect on the expression of some proteins involved in APAP-cell death mechanism and cellular antioxidant defense system.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec><title>Chemical Compounds and Reagents</title>
<p>Acetaminophen was purchased from MedChem Express (Monmouth Junction, NJ 08852, United States); Thiazolyl Blue Tetrazolium Bromide, &#x03B1;-Keto-glutaric Acid, L-Alanine, Thiobarbituric Acid, Trichloroacetic Acid, 2&#x2032;-7&#x2032;-Dichlorodihydrofluorescein diacetate (H<sub>2</sub>DCFDA), silymarin, JNK inhibitor SP600125, MITOISO2 &#x2013; Mitochondria Isolation Kit were purchased from Sigma&#x2013;Aldrich (St. Louis, MO, United States); M-PER Mammalian Protein Extraction Reagent, NE-PER<sup>&#x00AE;</sup> Nuclear and Cytoplasmic Proteins Extraction Kit, Halt protease inhibitor cocktail EDTA-Free 100X, Pierce bicinchoninic acid (BCA) Proteins Assay Kit, SuperSignal West Pico Chemiluminescent Substrate were all purchased from Thermo Fisher Scientific (Rockford, IL, United States). Rabbit polyclonal anti-CYP2E1 antibody (1:1500 dilution) was purchased from Sino Biological Inc. (Beijing, China); Rabbit polychonal anti-phospho-JNK1/JNK2 and JNK2 antibodies (1:1000 dilution) were purchased from Signalway Antibody (Baltimore, MD, United States); Rabbit polyclonal anti-MKP-1, Nrf2, Keap-1, AIF, COX IV, Lamin B and mouse polyclonal anti-Bax antibodies (all 1:1000 dilution) were purchased from Beijing Biosynthesis Biotechnology CO., LTD. (Beijing, China); Mouse monoclonal anti-&#x03B2;actin primary antibody (1:5000 dilution), horseradish peroxidase-conjugated goat anti-rabbit and anti-mouse IgG AP-linked secondary antibodies (1:2000 dilution) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, United States); TRIzol<sup>&#x00AE;</sup> Reagent was purchased from Ambion Life Technologies (Carlsbad, CA, United States); First-Strand cDNA Synthesis Kit was purchased from Promega (Madison, WI, United States); iTaq Universal SYBR Green Supermix Kit was purchased from Bio-Rad Laboratories (Hercules, CA, United States); All primers of the genes of interest were synthetized by TSINGKE Biological Technology Company (Beijing, China). All others reagent used in this study were of analytical grade.</p>
</sec>
<sec><title>Preparation of Plant Crude Extracts, Fractions and Sub-Fractions</title>
<p>Stem barks of <italic>K. grandifoliola</italic> were collected in June 2015 in Foumban (West Cameroon). The botanical identification of the plant was done at the Cameroon National Herbarium, where voucher specimen is kept under the reference number 23434 YA. <italic>K. grandifoliola</italic> most active fraction, namely KgF25 (methylene chloride/methanol 75:25, v/v) was prepared as previously described (<xref ref-type="bibr" rid="B40">Njayou et al., 2015</xref>, <xref ref-type="bibr" rid="B42">2016</xref>). Therefore, 8 g of KgF25 were subjected to silica gel 60 (particle size 40&#x2013;63 &#x03BC;m) column chromatography (column: d &#x00D7; h = 3.5 cm &#x00D7; 65 cm) and gradient of hexane/acetyl acetate (100:0 v/v to 0:100 v/v), then acetyl acetate/methanol (10:90 v/v to 0:100 v/v) were used for elution. The 47 chromatographic fractions containing crystalline solid obtained were analyzed by thin layer chromatography (TLC) and pooled into 5 sub-fractions namely KgF25sf1 (41 mg); KgF25sf2 (67 mg); KgF25sf3 (19 mg); KgF25sf4 (105 mg); and KgF25sf5 (55 mg) based on the similarity of their TLC profiles.</p>
</sec>
<sec><title>High Performance Liquid Chromatography (HPLC) Analysis and Purification</title>
<p>Following the preliminary results, the most active sub-fractions were analyzed by HPLC-ACN (Acetonitrile)-Standard-Method and compounds were purified by HPLC-ACN-Standard-Purify-Method. We used a Series 1200 Liquid Chromatograph (Agilent Technologies, Folsom, CA, United States) equipped with a vacuum degasser, a quaternary pump, an autosampler and a Diode-Array-Detector (DAD) connected to Agilent ChemStation software. An Eclipse XDB-C8 column (9.4 mm &#x00D7; 250 mm, 5 &#x03BC;m particle size) was used. The mobile phase was (A) water; (B) acetonitrile. The flow rate was 1 mL/min. The elution conditions were: B, 0&#x2013;15 min, increasing gradient from 0 to 30% B; 15&#x2013;20 min, linear gradient 100% B; 20&#x2013;25 min, linear gradient 30% B. The system operated at 28&#x00B0;C and the injection volume of each sample dilute in methanol (1 mg/mL) was 5 &#x03BC;L. The detection wavelength was kept at 254 nm.</p>
</sec>
<sec><title>Spectral Analysis of Purified Compounds</title>
<p>High-Resolution Mass Spectra (HRMS) of each pure sample dissolved in methanol was measured on an Agilent 1200 HPLC/6520 High-resolution mass spectrometer. NMR of each pure sample dissolved in DMSO (5 mg/mL) was recorded on BRUKER AV 500 spectrometer.</p>
</sec>
<sec><title>Cell and Culture Conditions</title>
<p>The normal human liver cell line L-02, (Cell Bank, Type Culture Collection of Institute of Microbiology, Chinese Academy of Sciences, Beijing, China) derived from an adult human normal liver were used. Cells were cultured in 100 mm dish and maintained in high glucose Dulbecco&#x2019;s Modified Eagle&#x2019;s Medium supplemented with 10% fetal bovine serum, <sc>L</sc>-glutamine (2 mM), penicillin (100 IU/mL), streptomycin (100 &#x03BC;g/mL) and amphotericin B (0.25 &#x03BC;g/mL) in an atmosphere of 5% CO<sub>2</sub> at 37&#x00B0;C.</p>
</sec>
<sec><title>Cells Treatment: General Procedure</title>
<p>In this study, silymarin and JNK-inhibitor SP600125 were used as reference compounds. APAP, silymarin, sub-fractions of KgF25 and isolated compounds were diluted in 20% DMSO [20% DMSO in phosphate-buffer saline (PBS)]. JNK-inhibitor SP600125 was dissolved in 100% DMSO. L-02 cells (approximately 2.10<sup>5</sup> cells/ml) in triplicate were seeded into 24-well plate labeled as control, APAP, standard and test (references or plant sample + APAP) and incubated for 24 h. Thereafter, the medium was replaced with fresh medium and cells were incubated in absence (control group) or in presence of APAP (APAP group), or in presence of APAP and references or plant sample (test groups) for different time points (6; 12; 24; and 36 h) depending on the downstream analysis.</p>
</sec>
<sec><title>Determination of the Toxic Concentration of APAP to Be Used</title>
<p>Cells were incubated in presence of APAP at the final concentrations of 0; 5; 10; 15; 20; and 30 mM. After 36 h, cell viability was measured using 3-(4, 5-dimethylthiosol-2-yl)-2, 5-diphenyl-2H-tetrazolium bromide kit (MTT; Sigma&#x2013;Aldrich) according to the manufacturer&#x2019;s instructions and the cell membrane integrity was assessed by measuring ALT activity released into the incubation medium using a calibration curve according to <xref ref-type="bibr" rid="B48">Reitman and Frankel (1957)</xref>. Cell viability was expressed as percentage of the control and the half lethal concentration (LC<sub>50</sub>) of APAP was determined and used as toxic concentration for the following experiments.</p>
</sec>
<sec><title>Hepatoprotective Activity Screening of Plant Sub-Fractions and Dose-Response Study of the Selected Active Sub-Fractions and Isolated Compounds</title>
<p>Cells were treated simultaneously with APAP (LC<sub>50</sub>) and plant sub-fractions or silymarin at the final concentration of 100 &#x03BC;g/mL for the hepatoprotective activity screening. After 36 h, cell viability and cell membrane integrity were assessed as abovementioned. Selected active sub-fractions and silymarin were tested at the final concentration of 25; 50; and 100 &#x03BC;g/mL for the dose-response study. Isolated compounds were then tested at 0; 10; 20; 30; and 40 &#x03BC;M and JNK inhibitor SP600125 at the final concentration of 0; 5; 10; 15; and 20 &#x03BC;M in order to minimize the effect of DMSO in APAP metabolism. After end time point, cell viability and membrane integrity were assessed and the half efficient concentrations (EC<sub>50</sub>) determined.</p>
</sec>
<sec><title>Propidium Iodide (PI) Staining</title>
<p>Cells were simultaneously treated with APAP and isolated compounds or JNK inhibitor at the determined concentration. After 36 h, cells were washed with cold PBS and stained with 10 &#x03BC;g/mL of PI solution for 5 min. Cells were then stained with 1 &#x03BC;g/mL of 4&#x2032;,6-diamino-2-phenylindole (DAPI) solution for 25 min and image were recorded with a fluorescence microscope (Advanced Microscopy Group).</p>
</sec>
<sec><title>Measurement of Intracellular ROS Level and Lipid Membrane Peroxidation</title>
<p>Intracellular ROS were measured according to reported method (<xref ref-type="bibr" rid="B27">Ji et al., 2009</xref>). Briefly, cells were treated with 20 &#x03BC;M H<sub>2</sub>DCFDA, APAP (10 mM) and isolated compounds or JNK inhibitor at the determined concentrations for 36 h. After treatment, supernatant was collected and cells were washed with PBS, immediately lysed in an appropriate lysis buffer, the whole cell lysates were centrifuged (10,000 <italic>g</italic>, 5 min, 4&#x00B0;C) and aliquot of lysate was used for fluorescence measurement at excitation 485 &#x00B1; 20 nm, emission 525 &#x00B1; 20 nm in a black wall with clear bottom 96-well plate using a spectrophotometer (SpectraMax M5, Molecular Devices) and presented as percentage of control. Lipid membrane peroxidation was evaluated through the malondialdehyde (MDA) level in the cellular supernatant by the thiobarbituric acid (TBA) method by using its molar extinction coefficient (&#x03B5;<sub>MDA</sub> = 1.56 &#x00D7; 10<sup>5</sup> M<sup>-1</sup>.Cm<sup>-1</sup>) as described by <xref ref-type="bibr" rid="B9">Buege and Aust (1978)</xref>.</p>
</sec>
<sec><title>Measurement of Cellular GSH Content</title>
<p>After treating cells with APAP and isolated compounds or JNK inhibitor for the indicated time, cells were harvested and lysed in lysis buffer. The whole cell lysates were centrifuged (10,000 <italic>g</italic>, 5 min, 4&#x00B0;C). The supernatant was collected and the GSH concentration was determined by using its molar extinction coefficient (&#x03B5;<sub>GSH</sub> = 13,600 M<sup>-1</sup>.Cm<sup>-1</sup>) by the 5,5-dithio-bis (2-nitrobenzoic acid) (DTNB) assay as described by <xref ref-type="bibr" rid="B13">Ellman (1959)</xref>.</p>
</sec>
<sec><title>Protein Extraction and Subcellular Fractionation</title>
<p>Cells were simultaneously treated with APAP and plant sub-fractions, silymarin, isolated compounds or JNK inhibitor at the determined concentration and incubated for different time points. Afterward, total proteins were extracted using M-PER Mammalian Protein Extraction Reagent (Thermo Scientific) containing 0.2% Halt protease inhibitor cocktail EDTA-Free 100X (Thermo Scientific); cytosolic and nuclear protein were extracted using NE-PER<sup>&#x00AE;</sup> Nuclear and Cytoplasmic Proteins Extraction Kit (Thermo Scientific); mitochondrial and cytosolic fractions were prepared with MITOISO2 - Mitochondria Isolation Kit (Sigma&#x2013;Aldrich); protein concentration in each sample was quantified with Pierce BCA Proteins Assay Kit (Thermo Scientific). All procedures were performed according to each manufacturer&#x2019;s instructions.</p>
</sec>
<sec><title>Western Blot Analysis</title>
<p>Equal amount of protein in Laemmli loading buffer (10 &#x03BC;l containing &#x2248; 50 &#x03BC;g of protein) was separated by 12 % Sodium-Dodecyl-Sulfate Poly-Acrylamide Gel Electrophoresis (SDS-PAGE) and electro-transferred into a Nitrocellulose Blotting Membrane (GE Healthcare, Life Science, Germany). The membrane were blocked with 5% w/v dehydrated skimmed milk in Tris-Buffered Saline Tween-20 (TBST: 10 mM Tris-HCl; 150 mM NaCl; 0.05% tween-20; pH 7.6); incubated overnight at 4&#x00B0;C with primary antibodies, rinsed, and then incubated 1 h at 25&#x00B0;C with horseradish peroxidase-conjugated secondary antibodies. Membrane was stained SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific, United States) and detection was performed by Enhanced Chemiluminescent Method which combines MicroChemi Unit and GelCapture Software. Densitometry analysis of the protein bands was performed using ImageJ Software.</p>
</sec>
<sec><title>RNA Isolation and cDNA Synthesis</title>
<p>L-02 cells were simultaneously treated with APAP and isolated compounds or JNK inhibitor and incubated for the indicated time. After treatment, Total RNA was extracted from cells using TRIzol<sup>&#x00AE;</sup> Reagent (Ambion, Life Technologies) according to the manufacturer&#x2019;s instruction. RNA concentration and purity were determined by reading the absorbance at 230; 260; and 280 nm by using a ND-2000 NanoDrop Spectrophotometer (Thermo Scientific). The 260/280 ratio of our RNA preparation ranged from 1.8 to 2.1 while the 260/230 ratio were greater than 2. These values indicate good RNA quality and therefore could be used for reverse transcription. First-strand synthesis cDNA was synthetized in the thermo cycler (Eastwin, Life Science) using Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV RT, Promega, Woods Hollow Road Madison, United States) as directed by the manufacturer.</p>
</sec>
<sec><title>Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) Analysis</title>
<p>Real-time qPCR was performed in Applied Biosystems 7500 System using iTaq<sup>TM</sup> Universal SYBR<sup>&#x00AE;</sup> Green Supermix (Bio-RAD Laboratories, Hercules, CA, United States) according to the manufacturer&#x2019;s instruction. Relative expression of target genes was normalized to the endogenous gene (GAPDH) used as internal control, analyzed by the 2<sup>-&#x0394;&#x0394;<italic>C</italic><sub>T</sub></sup> method using GenEX Software and given as ratio compared to the control group. All primers of interest genes were synthetized by TSINGKE Biological Technology Company (Beijing, China). Their sequences are presented in the <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Primer sequences used for quantitative real-time polymerase chain reaction (qRT-PCR).</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Genes</th>
<th valign="top" align="center" colspan="2">Primer Sequence (5&#x2032;____3&#x2032;)<hr/></th>
</tr>
<tr>
<td valign="top" align="left"></td>
<th valign="top" align="center">Forward</th>
<th valign="top" align="center">Reverse</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">CAT</td>
<td valign="top" align="center">AGGCCAGTCCTGACAAAATG</td>
<td valign="top" align="center">GAATCTCCGCACTTCTCCAG</td>
</tr>
<tr>
<td valign="top" align="left">SOD1</td>
<td valign="top" align="center">GAAGGTGTGGGGAAGCATTA</td>
<td valign="top" align="center">ACATTGCCCAAGTCTCCAAC</td>
</tr>
<tr>
<td valign="top" align="left">GST</td>
<td valign="top" align="center">TTGGCCTCCTGTATTCCTTG</td>
<td valign="top" align="center">AGCCAACTGGATGCTGAGTT</td>
</tr>
<tr>
<td valign="top" align="left">MAT1A</td>
<td valign="top" align="center">TAGGGACTGACCAGCAGCTT</td>
<td valign="top" align="center">AGGGACCAGGGAAAGAGAAA</td>
</tr>
<tr>
<td valign="top" align="left">GAPDH</td>
<td valign="top" align="center">CGACCACTTTGTCAAGCTCA</td>
<td valign="top" align="center">AGGGGTCTACATGGCAACTG</td>
</tr>
<tr>
<td valign="top" align="left"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib><italic>CAT, catalase; SOD1, superoxide dismutase1; GST, glutathione-<italic>S</italic>-Transferase; MAT1A, methionine adenosyltransferase 1A; GAPDH, glyceraldehyde-3-phosphate deshydrogenase.</italic></attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec><title>Statistical Analysis</title>
<p>Results are presented as mean &#x00B1; standard deviation (SD) of three independent experiments in triplicate. Comparisons between the mean values of various treatments groups were analyzed by one-way analysis of variance (ANOVA) followed by the Bonferroni&#x2019;s <italic>post hoc</italic> test whenever significant differences were observed between the variances. Comparisons were made between untreated group (DMSO control group) and intoxicated group (APAP-intoxicated group), and between APAP-intoxicated group and treated groups (APAP + tested or reference compounds). Differences between compared groups were considered significant for <italic>p</italic> &#x003C; 0.05. Analyses were performed using Prism 5.03 statistical software (Graph Pad Inc.).</p>
</sec>
</sec>
<sec><title>Results</title>
<sec><title>HPLC Fingerprint of Selected Active Sub-Fractions and Spectral Analysis of Purified Compounds</title>
<p>High Performance Liquid Chromatography chromatogram of KgF25sf1 (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S1A</xref>) showed several peaks with different retention time. The higher peak (retention time: 11.22 min) was designated as compound A (C-A). HPLC chromatogram of KgF25sf2 (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S1B</xref>) showed two main peaks with the retention time at 12.05 and 12.33 min and were designated as compound B (C-B) and (compound C) (C-C) respectively. C-A, C-B and C-C were purified and characterized. Comparison of theirs HRMS and NMR spectral data (Supplementary Figures <xref ref-type="supplementary-material" rid="SM1">S2</xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1">S10</xref>) with data literature (<xref ref-type="bibr" rid="B2">Atta-ur-Rahman et al., 2008</xref>; <xref ref-type="bibr" rid="B54">Tanaka et al., 2011</xref>, <xref ref-type="bibr" rid="B53">2012</xref>) allowed for the unambiguously identification of three known limonoids (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>) as 17-epi-methyl-6-hydroxyangolensate, 7-deacetoxy-7-oxogedunin and 7-deacetoxy-7R-hydroxygedunin, respectively, for C-A, C-B and C-C.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>High performance liquid chromatography (HPLC) chromatogram and chemical structures of purified compounds. <bold>(A)</bold> 17-epi-methyl-6-hydroxyangolensate; <bold>(B)</bold> 7-deacetoxy-7-oxogedunin and <bold>(C)</bold> 7-deacetoxy-7R-hydroxygedunin. Compounds were purified by HPLC-ACN-Standard-Purify-Method. Exact mass and chemical structures were determined by HRMS and <sup>1</sup>H and <sup>13</sup>C NMR, respectively.</p></caption>
<graphic xlink:href="fphar-08-00653-g001.tif"/>
</fig>
</sec>
<sec><title>APAP-Induced Cell Death and Loss of Membrane Integrity in L-02 Hepatocytes</title>
<p>As a normal hepatic cell line, L-02 cells are commonly used in hepatotoxicity studies induced by various xenobiotic (<xref ref-type="bibr" rid="B58">Xiao et al., 2014</xref>; <xref ref-type="bibr" rid="B47">Pang et al., 2016</xref>). Extra cellular level of ALT activity, a cytosolic enzyme is routinely used to evaluate the membrane integrity during APAP toxicity study <italic>in vitro</italic> (<xref ref-type="bibr" rid="B59">Xie et al., 2014</xref>). We evaluated the toxicity of APAP in L-02 cells by performing a dose-dependent study with APAP concentration range from 5 to 30 mM. Exposure of L-02 hepatocytes to APAP for 36 h dose-dependently resulted in significant (<italic>p</italic> &#x003C; 0.05) loss of cell viability (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>) and increase cellular ALT leakage into the incubation medium (<bold>Figure <xref ref-type="fig" rid="F2">2B</xref></bold>). The LC<sub>50</sub> was found to be 9.80 &#x00B1; 2.61 mM, and therefore, 10 mM of APAP was chosen as toxic concentration for the following experiment in this work.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Acetaminophen (APAP) induced cell death and loss of membrane integrity in L-02 hepatocytes. Cells were treated with various concentration of APAP (5&#x2013;30 mM) for 36 h. <bold>(A)</bold> Cell viability indicating dose-response of APAP toxicity; <bold>(B)</bold> loss of membrane integrity indicated by ALT activity found in the culture medium. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(5,30) = 377.7, <italic>P</italic> &#x003C; 0.0001 <bold>(A)</bold> and <italic>F</italic>(5,30) = 251.7, <italic>P</italic> &#x003C; 0.0001 <bold>(B)</bold>. <sup>&#x2217;</sup>Values significantly different compared to control (0 mM) (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test.</p></caption>
<graphic xlink:href="fphar-08-00653-g002.tif"/>
</fig>
</sec>
<sec><title>Hepatoprotective Activity Screening of KgF25 Sub-Fractions</title>
<p>The sub-fractions were tested against APAP-induced hepatotoxicity. As presented in <bold>Figures <xref ref-type="fig" rid="F3">3A,B</xref></bold>, respectively, sub-fractions KgF25sf1, KgF25sf2, and KgF25sf3 significantly (<italic>p</italic> &#x003C; 0.05) maintained cell viability and inhibited the release of ALT from the cell. These activities were not statistically different from that of silymarin, a well-known hepatoprotective flavonoids mixture. The above sub-fractions, being the most active, have been selected for the next part of the study.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Hepatoprotective screening activity of plants sub-fractions. L-02 cells were treated without or with APAP, or co-treated with APAP and KgF25 sub-fractions or silymarin for 36 h. After treatment, cell viability <bold>(A)</bold> and ALT activity <bold>(B)</bold> leakage into the incubation were determined. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(8,45) = 76.47, <italic>P</italic> &#x003C; 0.0001 <bold>(A)</bold> and <italic>F</italic>(8,45) = 180.3, <italic>P</italic> &#x003C; 0.0001 <bold>(B)</bold>. <sup>&#x0394;</sup>Values significantly different compared to control group (<italic>P</italic> &#x003C; 0.05); <sup>&#x2217;</sup>values significantly different compared to APAP intoxicated group (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test. Sil: silymarin; KgF25: methylene chloride/methanol (75:25, v/v) fraction of <italic>K. grandifoliola</italic>; KgF25sf1: sub-fraction 1 of KgF25; KgF25sf2: sub-fraction 2 of KgF25; KgF25sf3: sub-fraction 3 of KgF25; KgF25sf4: sub-fraction 4; of KgF25, KgF25sf5: sub-fraction 5 of KgF25.</p></caption>
<graphic xlink:href="fphar-08-00653-g003.tif"/>
</fig>
</sec>
<sec><title>Dose-Dependent Protective Effect of Active Sub-Fractions and Isolated Limonoids against APAP-Induced Toxicity</title>
<p>Incubation of cells with APAP (10 mM) for 36 h resulted in a significant (<italic>p</italic> &#x003C; 0.05) decrease of cell viability (<bold>Figure <xref ref-type="fig" rid="F4">4A</xref></bold>) and increase of ALT (<bold>Figure <xref ref-type="fig" rid="F4">4B</xref></bold>) activity leakage into the incubation medium. When hepatocytes were co-treated with active sub-fractions or silymarin at various concentrations (25; 50; and 100 &#x03BC;g/mL), a concentration-dependent protective and inhibitory effects on cell viability (<bold>Figure <xref ref-type="fig" rid="F4">4A</xref></bold>) and ALT leakage (<bold>Figure <xref ref-type="fig" rid="F4">4B</xref></bold>) was observed. Likewise, a similar effect on these parameters (<bold>Figures <xref ref-type="fig" rid="F4">4C,D</xref></bold>) was observed when cells were co-treated with isolated limonoids (10; 20; 30; and 40 &#x03BC;M) or JNK inhibitor SP600125 (5; 10; 15; and 20 &#x03BC;M). The EC<sub>50</sub> were 19.04 &#x00B1; 3.42 &#x03BC;M, 20.89 &#x00B1; 3.68 &#x03BC;M, 17.40 &#x00B1; 2.79 &#x03BC;M, and 13.76 &#x00B1; 2.37 &#x03BC;M, respectively, for compound A (17-epi-methyl-6-hydroxyangolensate), compound B (7-deacetoxy-7-oxogedunin), compound C (7-deacetoxy-7R-hydroxygedunin) and JNK inhibitor SP600125. Although the EC<sub>50</sub> of JNK inhibitor was lower than those of isolated limonoids, JNK inhibitor offered only partial protection (cell viability = 85.66 &#x00B1; 3.51%) while limonoids from <italic>K. grandifoliola</italic> showed almost total protection when added at 40 &#x03BC;M (cell viability &#x2265; 95%) as confirmed by PI cell death staining (<bold>Figure <xref ref-type="fig" rid="F5">5</xref></bold>). When active sub-fractions or isolated compounds were added at 100 &#x03BC;g/mL or 40 &#x03BC;M, the viability of hepatocytes were not statistically different from those of control group and the levels of extracellular ALT activity were lower. Based on this observation, these concentrations were chosen for the following experiments.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>Dose-dependent protective effect of active sub-fractions and isolated limonoids. Cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and active sub-fractions or silymarin (25; 50; and 100 &#x03BC;g/mL), isolated limonoids (10; 20; 30; and 40 &#x03BC;M) or JNK inhibitor (5; 10; 15; and 20 &#x03BC;M) for 36 h. <bold>(A,B)</bold> Effect of active sub-fractions on cell viability and ALT leakage, respectively. <bold>(C,D)</bold> Effect of isolated limonoids on cell viability and ALT leakage, respectively. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(6,14) = 33.82, <italic>P</italic> &#x003C; 0.0001 <bold>(A)</bold>; <italic>F</italic>(6,14) = 77.74, <italic>P</italic> &#x003C; 0.0001 <bold>(B)</bold>; <italic>F</italic>(5,12) = 48.96, <italic>P</italic> &#x003C; 0.0001 <bold>(C)</bold>; and <italic>F</italic>(5,12) = 128.3, <italic>P</italic> &#x003C; 0.0001 <bold>(D)</bold>. <sup>&#x0394;</sup>Values significantly different compared to control group (<italic>P</italic> &#x003C; 0.05); <sup>&#x2217;</sup>values significantly different compared to APAP intoxicated group (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test. KgF25: methylene chloride/methanol (75:25, v/v) fraction of <italic>K. grandifoliola</italic>; KgF25sf1: sub-fraction 1 of KgF25; KgF25sf2: sub-fraction 2 of KgF25; KgF25sf3: sub-fraction 3 of KgF25; C-A: 17-epi-methyl-6-hydroxyangolensate; C-B: 7-deacetoxy-7-oxogedunin; C-C: 7-deacetoxy-7R-hydroxygedunin; SP: JNK inhibitor SP600125.</p></caption>
<graphic xlink:href="fphar-08-00653-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>Propidium Iodide staining showing protective effect of isolated compounds against APAP-induced cell death. Cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and isolated compounds (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) for 36 h. After treatment, death cells were stained with PI (red) and DAPI (blue) was used to label the total number of cells. Each image recorded with fluorescence microscope represents one of three independent experiments in triplicate. SP: JNK inhibitor SP600125; C-A: 17-epi-methyl-6-hydroxyangolensate; C-B: 7-deacetoxy-7-oxogedunin; C-C: 7-deacetoxy-7R-hydroxygedunin.</p></caption>
<graphic xlink:href="fphar-08-00653-g005.tif"/>
</fig>
</sec>
<sec><title>Isolated Compounds Attenuated and Rescued APAP-Induced GSH Depletion, via Inhibition of Cytochrome P450 2E1 (CYP2E1) Expression</title>
<p>Acetaminophen hepatotoxicity is initiated by its biotransformation by CYP2E1 to the electrophile NAPQI, and overexpression of CYP2E1 plays a critical role in this process (<xref ref-type="bibr" rid="B21">Jaeschke et al., 2002</xref>). To evaluate whether the protective effect of active sub-fractions and isolated compounds was related to the expression of CYP2E1, the protein expression of CYP2E1 was determined by western blot analysis after co-treatment of cells with APAP (10 mM) and active sub-fractions (100 &#x03BC;g/mL) or isolated compounds (40 &#x03BC;M). The constitutive up-regulation of CYP2E1 expression by APAP treatment was significantly (<italic>p</italic> &#x003C; 0.05) down-regulated when cells were co-treated with active sub-fractions (<bold>Figures <xref ref-type="fig" rid="F6">6A,B</xref></bold>) or isolated compounds (<bold>Figures <xref ref-type="fig" rid="F6">6C,D</xref></bold>). This effect was comparable to that observed in silymarin (100 &#x03BC;g/mL) treated cells (<bold>Figure <xref ref-type="fig" rid="F6">6A</xref></bold>). NAPQI, the reactive metabolite of APAP can react with the sulfhydryl group of cysteine in GSH, leading to its depletion and therefore enhance cellular oxidative stress (<xref ref-type="bibr" rid="B22">Jaeschke et al., 2012</xref>). As shown in <bold>Figure <xref ref-type="fig" rid="F6">6E</xref></bold>, exposure to 10 mM APAP significantly (<italic>p</italic> &#x003C; 0.05) reduced cellular GSH levels within 6 h, followed by further depletion during the next 30 h. Co-treatment of L-02 cells with isolated limonoids significantly (<italic>p</italic> &#x003C; 0.05) attenuated GSH depletion after 6 h, followed by progressive restoration during the next 30 h. After 36 h, cellular GSH levels in co-treated cells were comparable to that of normal untreated cells.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption><p>Active sub-fractions and isolated limonoids down-regulated CYP2E1 proteins expression and rescued APAP-induced GSH depletion. Cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and active sub-fractions or silymarin (100 &#x03BC;g/mL), isolated compounds (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) for 6 h. After treatment, total proteins were extracted from cells and CYP2E1 expression was determined by western blotting. &#x03B2;-actin was used as loading control. Each blot represents one of three independent experiments. <bold>(A,C)</bold> Effect of active sub-fractions and isolated compounds on CYP2E1 expression, respectively. <bold>(B,D)</bold> Densitometry analysis of blots, respectively, for active sub-fractions and isolated compounds. <bold>(E)</bold> Effect of isolated compounds on cellular GSH. L-02 cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and isolated compounds (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) for 6, 12, 24, and 36 h. After each time point, total proteins were extracted and GSH contents were quantified. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(6,14) = 200.9, <italic>P</italic> &#x003C; 0.0001 <bold>(B)</bold>; <italic>F</italic>(5,12) = 219.6, <italic>P</italic> &#x003C; 0.0001 <bold>(D)</bold>; and <italic>F</italic>(5,12) = 59.88, <italic>P</italic> &#x003C; 0.0001 <bold>(D)</bold>. <sup>&#x0394;</sup>Values significantly different compared to control group (<italic>P</italic> &#x003C; 0.05); <sup>&#x2217;</sup>values significantly different compared to APAP intoxicated group (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test. Lane1: control; Lane2: APAP; Lane3: silymarin+APAP; Lane4: KgF25+APAP; Lane5: KgF25sf1+APAP; Lane6: KgF25sf2+APAP; Lane7: Kgf25sf3+APAP. Sil: silymarin; KgF25: methylene chloride/methanol (75:25, v/v) fraction of <italic>K. grandifoliola</italic>; KgF25sf1: sub-fraction 1 of KgF25; KgF25sf2: sub-fraction 2 of KgF25; KgF25sf3: sub-fraction 3 of KgF25; SP: JNK inhibitor SP600125; C-A: 17-epi-methyl-6-hydroxyangolensate; C-B: 7-deacetoxy-7-oxogedunin; C-C: 7-deacetoxy-7R-hydroxygedunin.</p></caption>
<graphic xlink:href="fphar-08-00653-g006.tif"/>
</fig>
</sec>
<sec><title>Isolated Limonoids Attenuated APAP-Induced ROS Generation and Lipid Peroxidation</title>
<p>Increase production of intracellular ROS occurring after GSH depletion plays an important role in APAP-induced injury (<xref ref-type="bibr" rid="B21">Jaeschke et al., 2002</xref>). <bold>Figure <xref ref-type="fig" rid="F7">7A</xref></bold> depicts the effect of APAP-induced intracellular ROS generation in L-02 cells and its significant annihilation by co-treatment with isolated limonoids from <italic>K. grandifoliola</italic>. Hepatocytes stressed with APAP showed significant (<italic>p</italic> &#x003C; 0.05) increase in ROS generation as compared to untreated cells. Co-treatment with isolated compounds (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) significantly (<italic>p</italic> &#x003C; 0.05) decreased ROS level as compared to APAP-treated cells. Overproduction of ROS initiates the process of lipid peroxidation in cell membranes and causes the destruction of cellular integrity as well as cell death (<xref ref-type="bibr" rid="B33">Kumari and Kakkar, 2012b</xref>). Lipid peroxidation was measured by estimating the concentration of MDA, an end product of lipid peroxidation into the incubation medium. As presented in <bold>Figure <xref ref-type="fig" rid="F7">7B</xref></bold>, oxidative stress induced by free radical due to APAP in the hepatocytes caused a significant (<italic>p</italic> &#x003C; 0.05) increase of MDA production. However, the MDA formation was significantly attenuated when cells were co-treated with isolated limonoids (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption><p>Limonoids from <italic>K. grandifoliola</italic> attenuated APAP-induced oxidative stress in L-02 cells. Cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and isolated compounds (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) for 36 h. After treatment, cellular ROS level <bold>(A)</bold> and MDA concentrations <bold>(B)</bold> in the incubation medium were measured. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(5,12) = 28.25, <italic>P</italic> &#x003C; 0.0001 <bold>(A)</bold> and <italic>F</italic>(5,12) = 303.0, <italic>P</italic> &#x003C; 0.0001 <bold>(B)</bold>. <sup>&#x0394;</sup>Values significantly different compared to control group (<italic>P</italic> &#x003C; 0.05); <sup>&#x2217;</sup>values significantly different compared to APAP intoxicated group (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test. SP: JNK inhibitor SP600125; C-A: 17-epi-methyl-6-hydroxyangolensate; C-B: 7-deacetoxy-7-oxogedunin; C-C: 7-deacetoxy-7R-hydroxygedunin.</p></caption>
<graphic xlink:href="fphar-08-00653-g007.tif"/>
</fig>
</sec>
<sec><title>Active Sub-Fractions and Isolated Compounds Prevented APAP-Induced JNK Activation and Mitochondrial Translocation of p-JNK in L-02 Hepatocytes</title>
<p>Recently, JNK activation and the mitochondrial translocation of p-JNK have been well established to play a major role in APAP-induced hepatotoxicity (<xref ref-type="bibr" rid="B16">Gunawan et al., 2006</xref>; <xref ref-type="bibr" rid="B18">Hanawa et al., 2008</xref>; <xref ref-type="bibr" rid="B59">Xie et al., 2014</xref>). To explore the effects of isolated compounds on JNK mediating cell death, total proteins were initially extracted 6 h after treating L-02 cells with 10 mM APAP or co-treated with APAP and active sub-fractions (100 &#x03BC;g/mL) or limonoids (40 &#x03BC;M). The lysates were probed for JNK2 and p-JNK by western blotting. Administration of APAP alone resulted in massive p-JNK while co-treatment with active sub-fractions (<bold>Figure <xref ref-type="fig" rid="F8">8A</xref></bold>) or isolated compounds (<bold>Figure <xref ref-type="fig" rid="F8">8B</xref></bold>) significantly (<italic>p</italic> &#x003C; 0.05) inhibited JNK activation.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption><p>Active sub-fractions and isolated limonoids prevented APAP-induced JNK activation. Cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and active sub-fractions or silymarin (100 &#x03BC;g/mL), isolated limonoids (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) for 6 h. After treatment, total proteins were extracted from cells and the lysates were probed for JNK2 and p-JNK by western blotting. &#x03B2;-actin was used as loading control. Each blot represents one of three independent experiments. <bold>(A,C)</bold> Effect of active sub-fractions and isolated compounds on JNK activation, respectively. <bold>(B,D)</bold> Densitometry analysis of blots, respectively, for active sub-fractions and isolated compounds. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(6,14) = 322.0, <italic>P</italic> &#x003C; 0.0001 <bold>(B)</bold> and <italic>F</italic>(5,12) = 1162.0, <italic>P</italic> &#x003C; 0.0001 <bold>(D)</bold>. <sup>&#x0394;</sup>Values significantly different compared to control group (<italic>P</italic> &#x003C; 0.05); <sup>&#x2217;</sup>values significantly different compared to APAP intoxicated group (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test. Lane1: control; Lane2: APAP; Lane3: silymarin+APAP; Lane4: KgF25+APAP; Lane5: KgF25sf1+APAP; Lane6: KgF25sf2+APAP; Lane7: Kgf25sf3+APAP. Sil: silymarin; KgF25: methylene chloride/methanol (75:25, v/v) fraction of <italic>K. grandifoliola</italic>; KgF25sf1: sub-fraction 1 of KgF25; KgF25sf2: sub-fraction 2 of KgF25; KgF25sf3: sub-fraction 3 of KgF25; SP: JNK inhibitor SP600125; C-A: 17-epi-methyl-6-hydroxyangolensate; C-B: 7-deacetoxy-7-oxogedunin; C-C: 7-deacetoxy-7R-hydroxygedunin.</p></caption>
<graphic xlink:href="fphar-08-00653-g008.tif"/>
</fig>
<p>Activated JNK translocate into mitochondria, leading to mitochondrial dysfunction and oxidant stress (<xref ref-type="bibr" rid="B22">Jaeschke et al., 2012</xref>). To determine whether isolated limonoids affect p-JNK translocation into mitochondria, cytosolic and mitochondrial fractions were prepared from L-02 cells and JNK activation was evaluated at 6 and 12 h after treatment. Similar to what was observed in total cell lysates, 10 mM APAP exposure caused JNK activation in the cytosol at 6 and 12 h (<bold>Figures <xref ref-type="fig" rid="F9">9A,B</xref></bold>). We observed in the mitochondria of APAP treated cells a modest, but significant (<italic>p</italic> &#x003C; 0.05) increase in p-JNK 6 h after APAP exposure (<bold>Figure <xref ref-type="fig" rid="F9">9A</xref></bold>) and massive p-JNK at 12 h (<bold>Figure <xref ref-type="fig" rid="F9">9B</xref></bold>). Co-treatment with isolated compounds prevented JNK activation in the cytosol at 6 and 12 h and its translocation into mitochondria (<bold>Figures <xref ref-type="fig" rid="F9">9A,B</xref></bold>). These effects were comparable to those observed in JNK inhibitor treated cells.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption><p>Limonoids from <italic>K. grandifoliola</italic> prevented mitochondrial p-JNK translocation. Cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and isolated limonoids (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) for 6 and 12 h. After treatment, p-JNK level was detected into the cytosolic and mitochondrial fractions by western blotting. JNK2 was used as internal control. Each blot represents one of three independent experiments. <bold>(A,B)</bold> Effect of isolated compounds on JNK activation, respectively, at 6 and 12 h after treatment. <bold>(C)</bold> densitometry analysis of blots. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(5,12) = 1119.0, <italic>P</italic> &#x003C; 0.0001 and <italic>F</italic>(5,12) = 1841.0, <italic>P</italic> &#x003C; 0.0001 <bold>(C)</bold>. <sup>&#x0394;</sup>Values significantly different compared to control group (<italic>P</italic> &#x003C; 0.05); <sup>&#x2217;</sup>values significantly different compared to APAP intoxicated group (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test. SP: JNK inhibitor SP600125; C-A: 17-epi -methyl-6-hydroxyangolensate; C-B: 7-deacetoxy-7-oxogedunin; C-C: 7-deacetoxy-7R-hydroxygedunin.</p></caption>
<graphic xlink:href="fphar-08-00653-g009.tif"/>
</fig>
</sec>
<sec><title>Limonoids from <italic>K. grandifoliola</italic> Prevented Mitochondrial Bax Translocation and Release of AIF from Mitochondria to the Cytosol</title>
<p>Amplification of the mitochondrial oxidant stress by the translocation of p-JNK triggers the opening of the MPT pore in the mitochondria, followed by the mitochondrial Bax (Bcl<sub>2</sub>-associated X protein) translocation. These effects are responsible for the translocation of mitochondrial intermembrane proteins such as AIF and endonuclease G to the nucleus as main cause of nuclear DNA damage and cell death after APAP overdose (<xref ref-type="bibr" rid="B4">Bajt et al., 2008</xref>, <xref ref-type="bibr" rid="B5">2011</xref>; <xref ref-type="bibr" rid="B49">Saito et al., 2010</xref>). To investigate the effect of isolated limonoids in these events, the release of AIF into the cytosol and mitochondrial translocation of Bax were observed by immunoblotting in APAP-intoxicated cells 12 h after exposure (<bold>Figures <xref ref-type="fig" rid="F10">10A,B</xref></bold>). Co-treatment of cells with isolated compounds (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) significantly (<italic>p</italic> &#x003C; 0.05) prevented the mitochondrial translocation of Bax and the release of AIF into the cytosol (<bold>Figures <xref ref-type="fig" rid="F10">10A,B</xref></bold>).</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption><p>Isolated compounds attenuated mitochondrial Bax translocation and release of AIF from mitochondria to cytosol. Cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and limonoids (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) for 12 h. After treatment, AIF and Bax protein levels <bold>(A)</bold> were detected into the cytosolic and mitochondrial fractions by western blotting. &#x03B2;-actin and COX IV (cytochrome oxidase IV) were used as loading control, respectively, for the cytosolic and mitochondrial fraction, respectively. Each blot represents one of three independent experiments. <bold>(B)</bold> Densitometry analysis of blots. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(5,12) = 671.2, <italic>P</italic> &#x003C; 0.0001 and <italic>F</italic>(5,12) = 317.5, <italic>P</italic> &#x003C; 0.0001 <bold>(B)</bold>. <sup>&#x0394;</sup>Values significantly different compared to control group (<italic>P</italic> &#x003C; 0.05); <sup>&#x2217;</sup>values significantly different compared to APAP intoxicated group (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test. SP: JNK inhibitor SP600125; C-A: 17-epi-methyl-6-hydroxyangolensate; C-B: 7-deacetoxy-7-oxogedunin; C-C: 7-deacetoxy-7R-hydroxygedunin.</p></caption>
<graphic xlink:href="fphar-08-00653-g010.tif"/>
</fig>
</sec>
<sec><title>Isolated Limonoid Up-Regulated Mkp-1 Protein Expression</title>
<p>Mkp-1, a phosphatase which preferentially inactivates the stress induced by JNK activation in most tissues, has been found to protect against APAP-hepatotoxicity (<xref ref-type="bibr" rid="B17">Hammer et al., 2006</xref>; <xref ref-type="bibr" rid="B56">Wancket et al., 2012</xref>). However, overexpression of ROS decreases its expression (<xref ref-type="bibr" rid="B29">Kamata et al., 2005</xref>). In search of the protective mechanism of isolated limonoids from <italic>K. grandifoliola</italic>, the Mkp-1 protein level has been evaluated by immunoblotting. As shown in <bold>Figures <xref ref-type="fig" rid="F11">11A,B</xref></bold>, exposure of L-02 hepatocytes for 6 h resulted in a marked decrease of Mkp-1 protein level. Co-treatment with silymarin (100 &#x03BC;g/ml) (<bold>Figure <xref ref-type="fig" rid="F11">11A</xref></bold>) or JNK inhibitor SP600125 (20 &#x03BC;M) (<bold>Figure <xref ref-type="fig" rid="F11">11B</xref></bold>) only attenuated this decreasing. However, co-treatment with active sub-fractions (100 &#x03BC;g/ml) (<bold>Figures <xref ref-type="fig" rid="F11">11A,C</xref></bold>) or isolated compounds (40 &#x03BC;M) (<bold>Figures <xref ref-type="fig" rid="F11">11B,D</xref></bold>) markedly increased the expression of Mkp-1 by up-to 1.8-fold as compared to the untreated cells.</p>
<fig id="F11" position="float">
<label>FIGURE 11</label>
<caption><p>Active sub-fractions and isolated Limonoids up-regulated Mkp-1 protein expression. Cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and active sub-fractions or silymarin (100 &#x03BC;g/mL), isolated compounds (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) for 6 h. After treatment, total proteins were extracted from cells and Mkp-1 expression was determined by western blotting. &#x03B2;-actin was used as loading control. Each blot represents one of three independent experiments. <bold>(A,B)</bold> Effect of active sub-fractions and isolated compounds on Mkp-1 expression, respectively. <bold>(C,D)</bold> Densitometry analysis of blots, respectively, for active sub-fractions and isolated compounds. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(6,14) = 307.1, <italic>P</italic> &#x003C; 0.0001 <bold>(C)</bold> and <italic>F</italic>(5,12) = 270.3, <italic>P</italic> &#x003C; 0.0001 <bold>(D)</bold>. <sup>&#x0394;</sup>Values significantly different compared to control group (<italic>P</italic> &#x003C; 0.05); <sup>&#x2217;</sup>values significantly different compared to APAP intoxicated group (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test. Lane1: control; Lane2: APAP; Lane3: silymarin+APAP; Lane4: KgF25+APAP; Lane5: KgF25sf1+APAP; Lane6: KgF25sf2+APAP; Lane7: Kgf25sf3+APAP. Sil: silymarin; KgF25: methylene chloride/methanol (75:25, v/v) fraction of <italic>K. grandifoliola</italic>; KgF25sf1: sub-fraction 1 of KgF25; KgF25sf2: sub-fraction 2 of KgF25; KgF25sf3: sub-fraction 3 of KgF25; SP: JNK inhibitor SP600125; C-A: 17-epi-methyl-6-hydroxyangolensate; C-B: 7-deacetoxy-7-oxogedunin; C-C: 7-deacetoxy-7R-hydroxygedunin.</p></caption>
<graphic xlink:href="fphar-08-00653-g011.tif"/>
</fig>
<sec><title>Limonoids of <italic>K. grandifoliola</italic> Induced Nuclear Translocation of Nrf2</title>
<p>Nrf2 plays a keys role in the cellular antioxidant defense system by regulating the transcriptional activation of various antioxidant enzymes (<xref ref-type="bibr" rid="B26">Jaiswal, 2004</xref>). Therefore, western blot analysis was performed to examine the ability of isolated limonoids to induce the nuclear translocation of Nrf2. As shown in <bold>Figure <xref ref-type="fig" rid="F12">12A</xref></bold>, co-treatment of L-02 cells with limonoids from <italic>K. grandifoliola</italic> induced the translocation of Nrf2 into the nucleus by up to two and threefold, respectively, at 12 h and 24 h after treatment, as compared to untreated cells. There was no obvious change in nuclear Nrf2 level of APAP or JNK inhibitor treated cells. Interestingly, 24 h after treatment, the nuclear translocation of Nrf2 was correlated to a significant (<italic>p</italic> &#x003C; 0.05) decrease of the expression of Keap-1 (an inhibitor of Nrf2 activation) into the cytosol in limonoids co-treated cells (<bold>Figures <xref ref-type="fig" rid="F12">12A,B</xref></bold>).</p>
<fig id="F12" position="float">
<label>FIGURE 12</label>
<caption><p>Isolated limonoids activated Nrf2-Keap-1 antioxidant defense system. Cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and isolated limonoids (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) for 12 and 24 h. After treatment, Nrf2 level was detected into the nuclear fraction and Keap-1 level was detected at 24 h into the cytosolic fractions by western blotting <bold>(A)</bold>. Lamin-B and &#x03B2;-actin were used as loading control, respectively, for the nuclear and cytosolic fraction. Each blot represents one of three independent experiments. <bold>(B)</bold> Densitometry analysis of blots. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(5,12) = 370.8, <italic>P</italic> &#x003C; 0.0001 and <italic>F</italic>(5,12) = 48.80, <italic>P</italic> &#x003C; 0.0001 <bold>(B)</bold>. <sup>&#x0394;</sup>Values significantly different compared to control group (<italic>P</italic> &#x003C; 0.05); <sup>&#x2217;</sup>values significantly different compared to APAP intoxicated group (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test. SP: JNK inhibitor SP600125; C-A: 17-epi-methyl-6-hydroxyangolensate; C-B: 7-deacetoxy-7-oxogedunin; C-C: 7-deacetoxy-7R-hydroxygedunin.</p></caption>
<graphic xlink:href="fphar-08-00653-g012.tif"/>
</fig>
</sec>
</sec>
<sec><title>Limonoids from <italic>K. grandifoliola</italic> Increased mRNA Expression Levels of Antioxidants Enzymes</title>
<p>Gene&#x2019;s expression studies are useful supplements to protein examination, as the mRNA levels represent a snapshot of the cell activity at a given time. Thus, the effect of isolated limonoids was evaluated by qRT-PCR on the expression of the antioxidant enzymes, CAT, SOD1, and GST chosen as target genes of Nrf2. In parallel, the expression of MAT1A was also evaluated. As presented in <bold>Figure <xref ref-type="fig" rid="F13">13</xref></bold>, exposure of cells to 10 mM APAP for 36 h significantly reduced the mRNA levels of CAT, SOD1, GST, and MAT1A. In limonoids co-treated cells, the mRNA levels of CAT (<bold>Figure <xref ref-type="fig" rid="F13">13A</xref></bold>) and GST (<bold>Figure <xref ref-type="fig" rid="F13">13C</xref></bold>) were increased by up-to 2.8-fold as compared to the untreated cells. Similarly, the mRNA levels of SOD (<bold>Figure <xref ref-type="fig" rid="F13">13B</xref></bold>) and MAT1A (<bold>Figure <xref ref-type="fig" rid="F13">13D</xref></bold>) were also increased by up-to 1.77-fold.</p>
<fig id="F13" position="float">
<label>FIGURE 13</label>
<caption><p>Limonoids from <italic>K. grandifoliola</italic> increased mRNA levels of CAT, SOD1, GST, and MAT1A genes. Cells were treated without or with APAP (10 mM), or co-treated with APAP (10 mM) and isolated limonoids (40 &#x03BC;M) or JNK inhibitor (20 &#x03BC;M) for 36 h. After treatment, RNA was extracted from cells and relative mRNA expression level of CAT <bold>(A)</bold>, SOD <bold>(B)</bold>, GST <bold>(C)</bold>, and MAT1A <bold>(D)</bold> were determined by qRT-PCR. GAPDH was used as internal control. Values are means &#x00B1; SD of three independent experiments in triplicate. ANOVA analysis: <italic>F</italic>(5,12) = 70.43, <italic>P</italic> &#x003C; 0.0001 <bold>(A)</bold>; <italic>F</italic>(5,12) = 45.72, <italic>P</italic> &#x003C; 0.0001 <bold>(B)</bold>; <italic>F</italic>(5,12) = 113.0, <italic>P</italic> &#x003C; 0.0001 <bold>(C)</bold>; and <italic>F</italic>(5,12) = 20.65, <italic>P</italic> &#x003C; 0.0001 <bold>(D)</bold>. <sup>&#x0394;</sup>Values significantly different compared to control group (<italic>P</italic> &#x003C; 0.05); <sup>&#x2217;</sup>values significantly different compared to APAP intoxicated group (<italic>P</italic> &#x003C; 0.05) using Bonferroni&#x2019;s test. SP: JNK inhibitor SP600125; C-A: 17-epi-methyl-6-hydroxyangolensate; C-B: 7-deacetoxy-7-oxogedunin; C-C: 7-deacetoxy-7R-hydroxygedunin.</p></caption>
<graphic xlink:href="fphar-08-00653-g013.tif"/>
</fig>
</sec>
</sec>
<sec><title>Discussion</title>
<p>Previous studies conducted have shown the hepatoprotective potential of <italic>K. grandifoliola</italic> and a highly active fraction has been isolated (<xref ref-type="bibr" rid="B40">Njayou et al., 2015</xref>, <xref ref-type="bibr" rid="B42">2016</xref>). The main purpose of the present study was to identify compounds from the plant bearing hepatoprotective activity and the related molecular mechanism against APAP-induced hepatotoxicity in normal human liver L-02 cells. The results showed the protective action of three isolated known limonoids (17-epi-methyl-6-hydroxylangolensate, 7-deacetoxy-7-oxogedunin and deacetoxy-7R-hydroxygedunin) which was evidenced not only by their ability to alter the critical events in APAP-cell death mechanism, but also by their capacity to improve the cellular antioxidant defense system.</p>
<p>Acetaminophen continues to serve as an important model of DILI for phytotherapeutics and other natural compounds (<xref ref-type="bibr" rid="B23">Jaeschke et al., 2011</xref>, <xref ref-type="bibr" rid="B24">2013</xref>). The hepatotoxicity of APAP is initiated firstly by its bio-activation to form a reactive metabolite NAPQI, and overexpression of CYP2E1 plays a critical role in this process (<xref ref-type="bibr" rid="B21">Jaeschke et al., 2002</xref>). Accumulated NAPQI depletes GSH pool due to the saturation of both glucuronidation and sulfatation pathways (<xref ref-type="bibr" rid="B20">Hinson et al., 2010</xref>); leading to excessive generation of ROS which subsequently triggers the process of lipid membrane peroxidation and causes destruction of cells components and cell death (<xref ref-type="bibr" rid="B21">Jaeschke et al., 2002</xref>; <xref ref-type="bibr" rid="B50">Schnackenberg et al., 2009</xref>). In this study, APAP was used at the determined concentration of 10 mM. This concentration was found to be toxic for L-02 hepatocytes after 36 h of incubation leading to about 50% decrease of cell viability and great increase of ALT leakage into the incubation medium (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). These observations could be the consequence of metabolic activation of APAP as proven by the overexpression of CYP2E1 (<bold>Figures <xref ref-type="fig" rid="F6">6A,B</xref></bold>), depletion of cellular GSH (<bold>Figure <xref ref-type="fig" rid="F6">6E</xref></bold>), overproduction of ROS (<bold>Figure <xref ref-type="fig" rid="F7">7A</xref></bold>) and increase formation of MDA (<bold>Figure <xref ref-type="fig" rid="F7">7B</xref></bold>) when L-02 hepatocytes were incubated in presence of APAP alone. However, co-treatment of cells with active sub-fractions, isolated limonoids or JNK inhibitor dose-dependently prevented cell death and ALT leakage into the incubation medium (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>). Likewise, significant inhibition of CYP2E1 expression (<bold>Figures <xref ref-type="fig" rid="F6">6C,D</xref></bold>), restoration of cellular GSH (<bold>Figure <xref ref-type="fig" rid="F6">6E</xref></bold>), attenuation of ROS generation (<bold>Figure <xref ref-type="fig" rid="F7">7A</xref></bold>) and inhibition of lipid peroxidation (<bold>Figure <xref ref-type="fig" rid="F7">7B</xref></bold>) were observed in limonoids co-treated cells. These results suggest that limonoids from <italic>K. grandifoliola</italic> protect L-02 hepatocytes against APAP-induced oxidative injury. Similarly, lupeol, a triterpenoid compound found in many plant species including mango, olive and fig was evidenced to protect primary rat hepatocytes against APAP-induced oxidative damage through inhibition of GSH depletion, ROS production and lipid membrane peroxidation (<xref ref-type="bibr" rid="B33">Kumari and Kakkar, 2012b</xref>).</p>
<p>The second hit which plays a major role during APAP cell death mechanism has been well established as JNK activation (<xref ref-type="bibr" rid="B16">Gunawan et al., 2006</xref>; <xref ref-type="bibr" rid="B18">Hanawa et al., 2008</xref>; <xref ref-type="bibr" rid="B49">Saito et al., 2010</xref>). In fact, early oxidant stress which occurs after GSH depletion initiates the activation of various MAP Kinases. The activities of different kinases converge to the phosphorylation of JNK, which then translocates into the mitochondria and amplifies the mitochondrial oxidant stress (<xref ref-type="bibr" rid="B38">Nakagawa et al., 2008</xref>; <xref ref-type="bibr" rid="B49">Saito et al., 2010</xref>). This mitochondrial oxidant stress leads to the opening of the membrane permeability transition (MPT) pore with collapse of the membrane potential and cessation of ATP synthesis. In addition, opening of MPT pore causes mitochondrial Bax translocation and mitochondrial matrix swelling, with the rupture of outer membrane and the release of intermembrane proteins, such as endonuclease G and AIF, which translocate into the nucleus and induce DNA damage (<xref ref-type="bibr" rid="B3">Bajt et al., 2006</xref>, <xref ref-type="bibr" rid="B4">2008</xref>). Taking together, these events have been recognized as the main cause of cell death (<xref ref-type="bibr" rid="B5">Bajt et al., 2011</xref>; <xref ref-type="bibr" rid="B22">Jaeschke et al., 2012</xref>; <xref ref-type="bibr" rid="B59">Xie et al., 2014</xref>). In support of these events in our study, phosphorylation of JNK (<bold>Figure <xref ref-type="fig" rid="F8">8</xref></bold>), mitochondrial translocation of p-JNK (<bold>Figure <xref ref-type="fig" rid="F9">9</xref></bold>) and Bax (<bold>Figure <xref ref-type="fig" rid="F10">10</xref></bold>), and release of AIF into the cytosol (<bold>Figure <xref ref-type="fig" rid="F10">10</xref></bold>) were observed in APAP-treated L-02 hepatocytes. All these parameters were effectively attenuated when cells were co-treated with isolated limonoids and their effects were comparable to those observed in JNK inhibitor co-treated cells. These findings suggest that inhibition of JNK activation contributes to the protective effect of these limonoids. These results are also in agreement with previous reports documenting that pharmacological inhibition of JNK phosphorylation or the silencing of JNK gene expression resulted in reduced liver injury after APAP overdose (<xref ref-type="bibr" rid="B16">Gunawan et al., 2006</xref>; <xref ref-type="bibr" rid="B19">Henderson et al., 2007</xref>; <xref ref-type="bibr" rid="B18">Hanawa et al., 2008</xref>).</p>
<p>Since previous studies have demonstrated that JNK activation is a key event that perpetuates hepatocellular damage during APAP hepatotoxicity (<xref ref-type="bibr" rid="B16">Gunawan et al., 2006</xref>; <xref ref-type="bibr" rid="B18">Hanawa et al., 2008</xref>; <xref ref-type="bibr" rid="B49">Saito et al., 2010</xref>), we assessed the effect of isolated limonoids on the expression of Mkp-1, a primary phosphatase responsible for dephosphorylating JNK (<xref ref-type="bibr" rid="B30">Keyse, 2000</xref>; <xref ref-type="bibr" rid="B17">Hammer et al., 2006</xref>). It has been reported that Mkp-1 protects mice against APAP-hepatotoxicity (<xref ref-type="bibr" rid="B56">Wancket et al., 2012</xref>). However, excess ROS generated during toxic hepatic injuries inhibits Mkp-1 and prolongs JNK activation which perpetuates hepatic damage (<xref ref-type="bibr" rid="B29">Kamata et al., 2005</xref>; <xref ref-type="bibr" rid="B7">Boutros et al., 2008</xref>; <xref ref-type="bibr" rid="B56">Wancket et al., 2012</xref>). In this study, we observed a significant decreased of Mkp-1 protein level (<bold>Figures <xref ref-type="fig" rid="F11">11A,B</xref></bold>) in APAP treated L-02 hepatocytes which effectively correlates with overproduction of ROS and sustained JNK activation. Co-treatment of cells with JNK inhibitor SP600125 only attenuated this decreasing (<bold>Figure <xref ref-type="fig" rid="F11">11B</xref></bold>). In contrast, when cells were co-treated with isolated limonoids, Mkp-1 protein levels were increased by up-to 1.8-fold as compared to untreated cells. These findings suggest that inhibition of JNK activation may be due to the up-regulation of Mkp-1 expression which could therefore contributes to protect L-02 hepatocytes against APAP-toxicity.</p>
<p>The transcription factor Nrf2, which regulates the transcriptional activation of various antioxidant enzymes has been reported to play a key role in protecting against hepatotoxicity of several chemicals (<xref ref-type="bibr" rid="B15">Gum and Cho, 2013</xref>; <xref ref-type="bibr" rid="B47">Pang et al., 2016</xref>). Under normal condition, Nrf2 is located into the cytosol, where it forms an inactive complex with it repressor Keap-1 (<xref ref-type="bibr" rid="B26">Jaiswal, 2004</xref>). Upon stimulation, Nrf2 dissociates from Keap-1, translocates into the nucleus where it binds to ARE and promote the expression of antioxidant enzymes (<xref ref-type="bibr" rid="B39">Niture et al., 2010</xref>). Therefore, up-regulation of Nrf2 in the nucleus can result in a reduction of ROS, and correspondingly, protects cells against APAP-toxicity. In our study, immunoblotting analysis in cells treated with APAP alone or co-treated with JNK inhibitor showed no obvious changes neither in nuclear Nrf2 protein level after 12 h or 24 h of treatment nor in cytosolic Keap-1 protein level after 24 h of treatment (<bold>Figure <xref ref-type="fig" rid="F12">12</xref></bold>). However, in limonoids co-treated cells, the nuclear protein level was increased by up to two and threefold, respectively, at 12 and 24 h after treatment. This effect was correlated with a significant (<italic>p</italic> &#x003C; 0.05) decrease of cytosolic keap-1 protein level (<bold>Figure <xref ref-type="fig" rid="F12">12</xref></bold>). Nrf2 target genes include antioxidant and detoxification enzymes as CAT, SOD1, and GST (<xref ref-type="bibr" rid="B26">Jaiswal, 2004</xref>). GST uses GSH to detoxicate the xenobiotic or their reactive metabolites in the liver. SOD dismutase superoxide anions into hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Then, CAT metabolizes H<sub>2</sub>O<sub>2</sub> to O<sub>2</sub> and H<sub>2</sub>O (<xref ref-type="bibr" rid="B28">Kaiiska et al., 2000</xref>; <xref ref-type="bibr" rid="B12">Dai et al., 2006</xref>). The expression of these enzymes decreases during APAP overdose (<xref ref-type="bibr" rid="B32">Kumari and Kakkar, 2012a</xref>). In the present study, CAT, SOD and GST mRNA levels were significantly (<italic>p</italic> &#x003C; 0.05) reduced in L-02 cells in response to APAP treatment alone (<bold>Figure <xref ref-type="fig" rid="F13">13</xref></bold>). In contrast, CAT, SOD, and GST mRNA levels were significantly (<italic>p</italic> &#x003C; 0.05) increased in limonoids co-treated cells. Taking together, these observations suggest that limonoids from <italic>K. grandifoliola</italic> stimulate Nrf2, which then dissociates from Keap-1, translocates into the nucleus and enhances the expression of CAT, SOD, and GST, and contributes therefore to the protection of L-02 hepatocytes against APAP-toxicity.</p>
<p>Methionine adenosyltransferase-1A is the enzyme responsible for the synthesis of <italic>S</italic>-adenosyl-<sc>L</sc>-methionine (SAM), the main precursor of GSH in the liver (<xref ref-type="bibr" rid="B34">Lieber, 2002</xref>). Previous studies report that depletion of the liver GSH content induced by various hepatotoxins is largely due to the decrease of MAT1A expression (<xref ref-type="bibr" rid="B8">Brown et al., 2010</xref>; <xref ref-type="bibr" rid="B10">Cederbaum, 2010</xref>). In our study, the significant (<italic>p</italic> &#x003C; 0.05) decrease of MAT1A mRNA level (<bold>Figure <xref ref-type="fig" rid="F13">13D</xref></bold>) observed in APAP-treated cells effectively correlated with the depletion of cellular GSH. Co-treatment of cells with limonoids significantly (<italic>p</italic> &#x003C; 0.05) increased MAT1A mRNA level. These data suggest that restoration of GSH observed in limonoids co-treated cells could be due to the increase expression of MAT1A.</p>
<p>On a structural basis, limonoids isolated in this study are related to two groups. Compound A (17-epi-methyl-6-hydroxylangolensate) is a derivative of methylangolensate while compound B (7-deacetoxy-7-oxogedunin) and C (deacetoxy-7R-hydroxygedunin) derive from gedunin. More than one hundred different natural limonoids have been isolated and are of diverse structural and biological activities that encompass antiparasitic, anticancer, antioxidant, anti-inflammatory, neuroprotective, antiplasmodial, antibacterial&#x2026; (<xref ref-type="bibr" rid="B55">Tundis et al., 2014</xref>). Methylangolensate has been demonstrated to inhibit NF-kB signaling pathway while a degradation product of limonoids, Fraxinellone exhibits anti-inflammatory activity via inhibition of Ik-B kinase (IKK) and extracellular signal-related kinase (ERK1/2) phosphorylation without affecting c-Jun N-terminal kinase (JNK1/2) and p38 phosphorylation (<xref ref-type="bibr" rid="B31">Kim et al., 2009</xref>). Compounds B and C which are structurally close possess antiproliferative activity through modulation of the 90-kDa heat shock protein (<xref ref-type="bibr" rid="B55">Tundis et al., 2014</xref>). Due to the great diversity of the structure and biological activities of limonoids, extensive studies are needed in order to relate the structure type to the molecular activities. However, this study provides for the first time evidence of the action of two structural diverse limonoids on the signaling pathway of APAP-induced hepatotoxicity in L-02 cells line through up-regulation of Mkp-1, an endogenous inhibitor of JNK phosphorylation, and nuclear translocation of Nrf2, a transcription factor that regulates the expression of numerous antioxidant enzymes.</p>
</sec>
<sec><title>Conclusion</title>
<p>Our findings demonstrated that limonoids isolated from <italic>K. grandifoliola</italic> protect normal human liver L-02 cells against APAP-induced hepatotoxicity mainly through induction of Mkp-1 and nuclear translocation of Nrf2. Also, further analysis including <italic>in vivo</italic> and toxicological studies are needed to select the most potent compound that may be useful as therapeutic agents against DILI.</p>
</sec>
<sec><title>Author Contributions</title>
<p>AK, FN, and PM defined the research subject and its aims, conceived and designed the experiments. GG, FY, and PM provided facilities to perform the work. AK, RT, HH, FS, and BO prepared the compounds and performed the experiments. AK, FN, FY, and GG analyzed the data and wrote the paper. All the authors read and approved the final version of this manuscript.</p>
</sec>
<sec><title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was co-supported by the International Center for Genetic Engineering and Biotechnology (ICGEB) [grant number S/CMR15-06] and the Organization for the Prohibition of Chemical Weapons (OPCW) [grant number F/4223-2].</p>
</fn>
</fn-group>
<ack>
<p>The authors thank the Department of Biochemistry, University of Yaound&#x00E9; 1 and the Institute of Microbiology, Chinese Academy of Sciences for providing the facilities to carry out this research.</p>
</ack>
<sec sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fphar.2017.00653/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fphar.2017.00653/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.DOC" id="SM1" mimetype="application/msword" xmlns:xlink="http://www.w3.org/1999/xlink">
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adeyemi</surname> <given-names>A.</given-names></name> <name><surname>Gbilade</surname> <given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Antianaemic activity of <italic>Spondias mombin</italic> and <italic>Khaya grandifoliola</italic> aqueous extracts on rats.</article-title> <source><italic>J. Pharm. Bioresour.</italic></source> <volume>3</volume> <fpage>94</fpage>&#x2013;<lpage>97</lpage>.</citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atta-ur-Rahman Zareen</surname> <given-names>S.</given-names></name> <name><surname>Choudhary</surname> <given-names>M. I.</given-names></name> <name><surname>Akhtar</surname> <given-names>M. N.</given-names></name> <name><surname>Khan</surname> <given-names>S. N.</given-names></name></person-group> (<year>2008</year>). <article-title>&#x03B1;-glucosidase inhibitory activity of Triterpenoids from <italic>Cichorium intybus</italic>.</article-title> <source><italic>J. Nat. Prod.</italic></source> <volume>71</volume> <fpage>910</fpage>&#x2013;<lpage>913</lpage>. <pub-id pub-id-type="doi">10.1021/np800001v</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bajt</surname> <given-names>M. L.</given-names></name> <name><surname>Cover</surname> <given-names>C.</given-names></name> <name><surname>Lemasters</surname> <given-names>J. J.</given-names></name> <name><surname>Jaeschke</surname> <given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver injury.</article-title> <source><italic>Toxicol. Sci.</italic></source> <volume>94</volume> <fpage>217</fpage>&#x2013;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfl077</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bajt</surname> <given-names>M. L.</given-names></name> <name><surname>Farhood</surname> <given-names>A.</given-names></name> <name><surname>Lemasters</surname> <given-names>J. J.</given-names></name> <name><surname>Jaeschke</surname> <given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Mitochondrial Bax translocation accelerates DNA fragmentation and cells necrosis in murine model of acetaminophen hepatotoxicity.</article-title> <source><italic>J. Pharmacol. Exp. Ther.</italic></source> <volume>324</volume> <fpage>8</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.107.129445</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bajt</surname> <given-names>M. L.</given-names></name> <name><surname>Ramachandran</surname> <given-names>A.</given-names></name> <name><surname>Yan</surname> <given-names>M. H.</given-names></name> <name><surname>Lebofsky</surname> <given-names>M.</given-names></name> <name><surname>Farhood</surname> <given-names>A.</given-names></name> <name><surname>Lemasters</surname> <given-names>J. J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity.</article-title> <source><italic>Toxicol. Sci.</italic></source> <volume>122</volume> <fpage>598</fpage>&#x2013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfr116</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bickii</surname> <given-names>J.</given-names></name> <name><surname>Njifutie</surname> <given-names>N.</given-names></name> <name><surname>Foyere</surname> <given-names>J. A.</given-names></name> <name><surname>Basco</surname> <given-names>L. K.</given-names></name> <name><surname>Ringwald</surname> <given-names>P.</given-names></name></person-group> (<year>2000</year>). <article-title>In vitro antimalarial activity of limonoids from <italic>Khaya grandifoliola</italic> C.D.C. (Meliaceae).</article-title> <source><italic>J. Ethnopharmacol.</italic></source> <volume>69</volume> <fpage>27</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-8741(99)00117-8</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boutros</surname> <given-names>T.</given-names></name> <name><surname>Nantel</surname> <given-names>A.</given-names></name> <name><surname>Emadali</surname> <given-names>A.</given-names></name> <name><surname>Tzinmas</surname> <given-names>G.</given-names></name> <name><surname>Conzen</surname> <given-names>S.</given-names></name> <name><surname>Chevet</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>The MAP Kinase phosphatase-1 Mkp-1/DUSP-1 is a critical regulator of human liver response to transplantation.</article-title> <source><italic>Am. J. Transplant.</italic></source> <volume>8</volume> <fpage>2558</fpage>&#x2013;<lpage>2568</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2008.02420.x</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>J. M.</given-names></name> <name><surname>Ball</surname> <given-names>J. G.</given-names></name> <name><surname>Hogsett</surname> <given-names>A.</given-names></name> <name><surname>Williams</surname> <given-names>T.</given-names></name> <name><surname>Valentinovic</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Temporal study of acetaminophen (APAP) and S-adenosyl-L-methionine (SAMe) effects sub-cellular hepatic SAMe levels and methionine adenolsyltransferase (MAT) expression and activity.</article-title> <source><italic>Toxicol. Appl. Pharmacol.</italic></source> <volume>247</volume> <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2010.04.018</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buege</surname> <given-names>J.</given-names></name> <name><surname>Aust</surname> <given-names>S.</given-names></name></person-group> (<year>1978</year>). <article-title>The thiobarbituric acid assay.</article-title> <source><italic>Methods Enzymol.</italic></source> <volume>52</volume> <fpage>306</fpage>&#x2013;<lpage>307</lpage>.</citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cederbaum</surname> <given-names>A. I.</given-names></name></person-group> (<year>2010</year>). <article-title>Hepatoprotective effects of S-adenosyl-L-methionine against alcohol-and cytochrome P450 2E1-induced liver injury.</article-title> <source><italic>World J. Gastroenterol.</italic></source> <volume>16</volume> <fpage>1366</fpage>&#x2013;<lpage>1376</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v16.i11.1366</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>S.</given-names></name> <name><surname>Zou</surname> <given-names>L.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Wu</surname> <given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>The protective effect of Glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis via up-regulation of Nrf2.</article-title> <source><italic>PLOS ONE</italic></source> <volume>8</volume>:<issue>e53662</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0053662</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname> <given-names>G.</given-names></name> <name><surname>He</surname> <given-names>L.</given-names></name> <name><surname>Chou</surname> <given-names>N.</given-names></name> <name><surname>Wan</surname> <given-names>Y. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Acetaminophen metabolism does not contribute to gender difference in its hepatotoxicity in mouse.</article-title> <source><italic>Toxicol. Sci.</italic></source> <volume>92</volume> <fpage>33</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfj192</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellman</surname> <given-names>G. L.</given-names></name></person-group> (<year>1959</year>). <article-title>Plasma antioxidants.</article-title> <source><italic>Arch. Biochem. Biophys.</italic></source> <volume>82</volume> <fpage>70</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/0003-9861(59)90090-6</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falodun</surname> <given-names>A.</given-names></name> <name><surname>Poh</surname> <given-names>C. F.</given-names></name> <name><surname>Adelusi</surname> <given-names>S. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Phytochemical and anti-inflammatory evaluation of <italic>Khaya grandifoliola</italic> stem bark extract.</article-title> <source><italic>Int. J. PharmTech Res.</italic></source> <volume>1</volume> <fpage>1061</fpage>&#x2013;<lpage>1064</lpage>.</citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gum</surname> <given-names>S.</given-names></name> <name><surname>Cho</surname> <given-names>M. K.</given-names></name></person-group> (<year>2013</year>). <article-title>Recent updates on acetaminophen-hepatotoxicity: the role of Nrf2 in hepatoprotection.</article-title> <source><italic>Toxicol. Res.</italic></source> <volume>29</volume> <fpage>165</fpage>&#x2013;<lpage>172</lpage>. <pub-id pub-id-type="doi">10.5487/TR.2013.29.3.165</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gunawan</surname> <given-names>B. K.</given-names></name> <name><surname>Liu</surname> <given-names>Z.</given-names></name> <name><surname>Han</surname> <given-names>D.</given-names></name> <name><surname>Hanawa</surname> <given-names>N.</given-names></name> <name><surname>Gaarde</surname> <given-names>W. A.</given-names></name> <name><surname>Kaplowitz</surname> <given-names>N.</given-names></name></person-group> (<year>2006</year>). <article-title>c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity.</article-title> <source><italic>Gastroenterology</italic></source> <volume>131</volume> <fpage>165</fpage>&#x2013;<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2006.03.045</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname> <given-names>M.</given-names></name> <name><surname>Mages</surname> <given-names>J.</given-names></name> <name><surname>Dietrich</surname> <given-names>H.</given-names></name> <name><surname>Servatus</surname> <given-names>A.</given-names></name> <name><surname>Howells</surname> <given-names>N.</given-names></name> <name><surname>Cato</surname> <given-names>A. C.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Dual specificity phosphatase-1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock.</article-title> <source><italic>J. Exp. Med.</italic></source> <volume>203</volume> <fpage>15</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20051753</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanawa</surname> <given-names>N.</given-names></name> <name><surname>Shinohara</surname> <given-names>M.</given-names></name> <name><surname>Saberi</surname> <given-names>B.</given-names></name> <name><surname>Gaarde</surname> <given-names>W. A.</given-names></name> <name><surname>Han</surname> <given-names>D.</given-names></name> <name><surname>Kaplowitz</surname> <given-names>N.</given-names></name></person-group> (<year>2008</year>). <article-title>Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>283</volume> <fpage>13565</fpage>&#x2013;<lpage>13577</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M708916200</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname> <given-names>N. C.</given-names></name> <name><surname>Pollock</surname> <given-names>K. J.</given-names></name> <name><surname>Frew</surname> <given-names>J.</given-names></name> <name><surname>Mackinnon</surname> <given-names>A. C.</given-names></name> <name><surname>Flavel</surname> <given-names>R. A.</given-names></name> <name><surname>Davis</surname> <given-names>R. J.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Critical role of c-Jun (NH2) terminal kinase in paracetamol-induced acute liver failure.</article-title> <source><italic>Gut</italic></source> <volume>56</volume> <fpage>982</fpage>&#x2013;<lpage>990</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2006.104372</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hinson</surname> <given-names>J. A.</given-names></name> <name><surname>Roberts</surname> <given-names>D. W.</given-names></name> <name><surname>James</surname> <given-names>L. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Mechanisms of acetaminophen-induced liver necrosis.</article-title> <source><italic>Handb. Exp. Pharmacol.</italic></source> <volume>196</volume> <fpage>369</fpage>&#x2013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-642-00663-0_12</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaeschke</surname> <given-names>H.</given-names></name> <name><surname>Gores</surname> <given-names>G. J.</given-names></name> <name><surname>Cederbaum</surname> <given-names>A. I.</given-names></name> <name><surname>Hinson</surname> <given-names>J. A.</given-names></name> <name><surname>Pessayre</surname> <given-names>D.</given-names></name> <name><surname>Lemasters</surname> <given-names>J. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Mechanisms of hepatotoxicity.</article-title> <source><italic>Toxicol. Sci.</italic></source> <volume>65</volume> <fpage>166</fpage>&#x2013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/65.2.166</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaeschke</surname> <given-names>H.</given-names></name> <name><surname>McGill</surname> <given-names>M. R.</given-names></name> <name><surname>Ramachandran</surname> <given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity.</article-title> <source><italic>Drug Metab. Rev.</italic></source> <volume>44</volume> <fpage>88</fpage>&#x2013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.3109/03602532.2011.602688</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaeschke</surname> <given-names>H.</given-names></name> <name><surname>McGill</surname> <given-names>M. R.</given-names></name> <name><surname>Williams</surname> <given-names>C. D.</given-names></name> <name><surname>Ramachandran</surname> <given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Current issues with acetaminophen hepatotoxicity&#x2013;a clinically relevant model to test the efficacy of natural products.</article-title> <source><italic>Life Sci.</italic></source> <volume>88</volume> <fpage>737</fpage>&#x2013;<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2011.01.025</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaeschke</surname> <given-names>H.</given-names></name> <name><surname>Williams</surname> <given-names>C. D.</given-names></name> <name><surname>McGill</surname> <given-names>M. R.</given-names></name> <name><surname>Xie</surname> <given-names>Y.</given-names></name> <name><surname>Ramachandran</surname> <given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products.</article-title> <source><italic>Food Chem. Toxicol.</italic></source> <volume>55</volume> <fpage>279</fpage>&#x2013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2012.12.063</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaeschke</surname> <given-names>H.</given-names></name> <name><surname>Xie</surname> <given-names>Y.</given-names></name> <name><surname>McGill</surname> <given-names>M. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Acetaminophen-induced liver injury: from animal models to humans.</article-title> <source><italic>J. Clin. Transl. Hepatol.</italic></source> <volume>2</volume> <fpage>153</fpage>&#x2013;<lpage>161</lpage>.</citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaiswal</surname> <given-names>A. K.</given-names></name></person-group> (<year>2004</year>). <article-title>Nrf2 signaling in coordinated activation of antioxidant gene expression.</article-title> <source><italic>Free Radic. Biol. Med.</italic></source> <volume>36</volume> <fpage>1199</fpage>&#x2013;<lpage>1207</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2004.02.074</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname> <given-names>L.</given-names></name> <name><surname>Liu</surname> <given-names>T.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name></person-group> (<year>2009</year>). <article-title>Protective mechanisms of N-Acetyl-cysteine against pyrrolizidine alkaloid clivorine-induced hepatotoxicity.</article-title> <source><italic>J. Cell. Biochem.</italic></source> <volume>108</volume> <fpage>424</fpage>&#x2013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.22269</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaiiska</surname> <given-names>M. B.</given-names></name> <name><surname>Gladen</surname> <given-names>B. C.</given-names></name> <name><surname>Baird</surname> <given-names>D. D.</given-names></name></person-group> (<year>2000</year>). <article-title>Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl4 poisoning?</article-title> <source><italic>Free Radic. Biol. Med</italic>.</source> <volume>28</volume> <fpage>838</fpage>&#x2013;<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1016/S0891-5849(00)00198-2</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamata</surname> <given-names>H.</given-names></name> <name><surname>Honda</surname> <given-names>S.</given-names></name> <name><surname>Maeda</surname> <given-names>S.</given-names></name> <name><surname>Chang</surname> <given-names>L.</given-names></name> <name><surname>Hirita</surname> <given-names>H.</given-names></name> <name><surname>Karin</surname> <given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Reactive oxygen species promote TNF&#x03B1;-induced death and sustained JNK activation by inhibiting MAP kinases phosphatases.</article-title> <source><italic>Cell</italic></source> <volume>120</volume> <fpage>649</fpage>&#x2013;<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.12.041</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keyse</surname> <given-names>S. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Protein phosphatases and the regulation of mitogen-activated protein kinase signaling.</article-title> <source><italic>Curr. Opin. Cell Biol.</italic></source> <volume>12</volume> <fpage>186</fpage>&#x2013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/S0955-0674(99)00075-7</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>W.</given-names></name> <name><surname>Fan</surname> <given-names>Y. Y.</given-names></name> <name><surname>Smith</surname> <given-names>R.</given-names></name> <name><surname>Patil</surname> <given-names>B.</given-names></name> <name><surname>Jayaprakasha</surname> <given-names>G. K.</given-names></name> <name><surname>McMurray</surname> <given-names>D. N.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Dietary curcumin and limonin suppress CD4<sup>+</sup> T-cell proliferation and interleukin-2 production in mice.</article-title> <source><italic>J. Nutr.</italic></source> <volume>139</volume> <fpage>1042</fpage>&#x2013;<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.3945/jn.108.102772</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumari</surname> <given-names>A.</given-names></name> <name><surname>Kakkar</surname> <given-names>P.</given-names></name></person-group> (<year>2012a</year>). <article-title>Lupeol prevents acetaminophen-induced in vivo hepatotoxicity by altering Bax/Bcl-2 and oxidative stress-mediated mitochondrial signaling cascade.</article-title> <source><italic>Life Sci.</italic></source> <volume>90</volume> <fpage>561</fpage>&#x2013;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2012.01.012</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumari</surname> <given-names>A.</given-names></name> <name><surname>Kakkar</surname> <given-names>P.</given-names></name></person-group> (<year>2012b</year>). <article-title>Lupeol protects against acetaminophen-induced oxidative stress and cell death in rat primary hepatocytes.</article-title> <source><italic>Food Chem. Toxicol.</italic></source> <volume>50</volume> <fpage>1781</fpage>&#x2013;<lpage>1789</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2012.02.042</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lieber</surname> <given-names>C. S.</given-names></name></person-group> (<year>2002</year>). <article-title>S-adenosyl-L-methionine: its role in the treatment of liver disorders.</article-title> <source><italic>Am. J. Clin. Nutr.</italic></source> <volume>76</volume> <fpage>1183S</fpage>&#x2013;<lpage>1187S</lpage>.</citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madrigal-Santill&#x00E1;n</surname> <given-names>E.</given-names></name> <name><surname>Madrigal-Bujaidar</surname> <given-names>E.</given-names></name> <name><surname>&#x00C1;lvarez-Gonz&#x00E1;lez</surname> <given-names>I.</given-names></name> <name><surname>Sumaya-Mart&#x00ED;nez</surname> <given-names>M. T.</given-names></name> <name><surname>Guti&#x00E9;rrez-Salinas</surname> <given-names>J.</given-names></name> <name><surname>Bautista</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Review of natural products with hepatoprotective effects.</article-title> <source><italic>World J. Gastroenterol.</italic></source> <volume>20</volume> <fpage>14787</fpage>&#x2013;<lpage>14804</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v20.i40.14787</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makinde</surname> <given-names>J. M.</given-names></name> <name><surname>Awe</surname> <given-names>S. O.</given-names></name> <name><surname>Agbedahunsi</surname> <given-names>J. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Effect of <italic>Khaya grandifoliola</italic> extract on <italic>Plasmodium berghei berghei</italic> in mice.</article-title> <source><italic>Phytother. Res.</italic></source> <volume>2</volume> <fpage>30</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.2650020104</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moundipa</surname> <given-names>P. F.</given-names></name> <name><surname>Njayou</surname> <given-names>F. N.</given-names></name> <name><surname>Yanditoum</surname> <given-names>S.</given-names></name> <name><surname>Sonk&#x00E9;</surname> <given-names>B.</given-names></name> <name><surname>Tchouanguep</surname> <given-names>F. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Medicinal plants used in Bamun region of the western province of Cameroon against Jaundice and other liver disorders.</article-title> <source><italic>Cam. J. Biochem. Sci.</italic></source> <volume>12</volume> <fpage>39</fpage>&#x2013;<lpage>46</lpage>.</citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname> <given-names>H.</given-names></name> <name><surname>Maeda</surname> <given-names>S.</given-names></name> <name><surname>Hikiba</surname> <given-names>Y.</given-names></name> <name><surname>Ohmae</surname> <given-names>T.</given-names></name> <name><surname>Shibata</surname> <given-names>W.</given-names></name> <name><surname>Yanai</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Deletion of apoptosis signal-regulating kinase-1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation.</article-title> <source><italic>Gastroenterology</italic></source> <volume>135</volume> <fpage>1311</fpage>&#x2013;<lpage>1321</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2008.07.006</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niture</surname> <given-names>S. K.</given-names></name> <name><surname>Kaspar</surname> <given-names>J. W.</given-names></name> <name><surname>Shen</surname> <given-names>J.</given-names></name> <name><surname>Jaiswal</surname> <given-names>A. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Nrf2 signaling and cell survival.</article-title> <source><italic>Toxicol. Appl. Pharmacol.</italic></source> <volume>244</volume> <fpage>37</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2009.06.009</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Njayou</surname> <given-names>F. N.</given-names></name> <name><surname>Amougou</surname> <given-names>A. M.</given-names></name> <name><surname>Tsayem</surname> <given-names>R. F.</given-names></name> <name><surname>Manjia</surname> <given-names>J. N.</given-names></name> <name><surname>Rudraiah</surname> <given-names>S.</given-names></name> <name><surname>Bradley</surname> <given-names>B.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Antioxidant fractions of <italic>Khaya grandifoliola</italic> C. DC., and <italic>Entada africana</italic> Guill et Perr. induce nuclear translocation of Nrf2 in HC-04 cells.</article-title> <source><italic>Cell Stress Chaperon.</italic></source> <volume>20</volume> <fpage>991</fpage>&#x2013;<lpage>1000</lpage>. <pub-id pub-id-type="doi">10.1007/s12192-015-0628-6</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Njayou</surname> <given-names>F. N.</given-names></name> <name><surname>Galani</surname> <given-names>T. B. R.</given-names></name> <name><surname>Ngadjui</surname> <given-names>T. B.</given-names></name> <name><surname>Moundipa</surname> <given-names>F. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Hepatoprotective activity of three Cameroonian medicinal plants against oxidative damages induced by paracetamol and CCl4 in primary rat hepatocytes.</article-title> <source><italic>Int. J. Pharm. Photon.</italic></source> <volume>104</volume> <fpage>306</fpage>&#x2013;<lpage>314</lpage>.</citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Njayou</surname> <given-names>F. N.</given-names></name> <name><surname>Kouam</surname> <given-names>A. F.</given-names></name> <name><surname>Simo</surname> <given-names>F. B. N.</given-names></name> <name><surname>Tchana</surname> <given-names>A. N.</given-names></name> <name><surname>Moundipa</surname> <given-names>P. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Active chemical fractions of stem bark extract of <italic>Khaya grandifoliola</italic> C.DC. and <italic>Entada africana</italic> Guill et Perr. synergistically protect primary rat hepatocytes against paracetamol-induced damage.</article-title> <source><italic>BMC Complement. Altern. Med.</italic></source> <volume>16</volume>:<issue>190</issue>. <pub-id pub-id-type="doi">10.1186/s12906-016-1169-y</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nourjah</surname> <given-names>P.</given-names></name> <name><surname>Ahmad</surname> <given-names>S. R.</given-names></name> <name><surname>Karwoski</surname> <given-names>C.</given-names></name> <name><surname>Willy</surname> <given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Estimates of acetaminophen (Paracetamol)-associated overdoses in the United States.</article-title> <source><italic>Pharmacoepidemiol. Drug Saf.</italic></source> <volume>15</volume> <fpage>398</fpage>&#x2013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1002/pds.1191</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odugbemi</surname> <given-names>T. O.</given-names></name> <name><surname>Akinsulure</surname> <given-names>O. R.</given-names></name> <name><surname>Aibinu</surname> <given-names>I. E.</given-names></name> <name><surname>Fabeku</surname> <given-names>P. O.</given-names></name></person-group> (<year>2007</year>). <article-title>Medicinal plants useful for malaria therapy in Okeigbo, Ondo State, Southwest Nigeria.</article-title> <source><italic>Afr. J. Tradit. Complement. Altern. Med.</italic></source> <volume>4</volume> <fpage>191</fpage>&#x2013;<lpage>198</lpage>.</citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olowokudejo</surname> <given-names>J. D.</given-names></name> <name><surname>Kadiri</surname> <given-names>A. B.</given-names></name> <name><surname>Travih</surname> <given-names>V. A.</given-names></name></person-group> (<year>2008</year>). <article-title>An ethnobotanical survey of herbal markets and medicinal plants in Lagos State of Nigeria.</article-title> <source><italic>Ethnobot. Lealf.</italic></source> <volume>12</volume> <fpage>851</fpage>&#x2013;<lpage>865</lpage>.</citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Onifade</surname> <given-names>A. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Effect of essential oils of some Meliaceaous plants on aflatoxin production and growth of <italic>Aspergillus parasiticus</italic>.</article-title> <source><italic>J. Food Technol.</italic></source> <volume>4</volume> <fpage>322</fpage>&#x2013;<lpage>324</lpage>.</citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname> <given-names>C.</given-names></name> <name><surname>Zheng</surname> <given-names>Z.</given-names></name> <name><surname>Shi</surname> <given-names>L.</given-names></name> <name><surname>Sheng</surname> <given-names>Y.</given-names></name> <name><surname>Wei</surname> <given-names>H.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Cafeic acid prevents acetaminophen-induced liver injury by activating the Keap1-Nrf2 antioxidative defense system.</article-title> <source><italic>Free Radic. Biol. Med.</italic></source> <volume>91</volume> <fpage>236</fpage>&#x2013;<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.12.024</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reitman</surname> <given-names>S.</given-names></name> <name><surname>Frankel</surname> <given-names>S.</given-names></name></person-group> (<year>1957</year>). <article-title>A colorimetric method for determination of serum glutamic oxaloacetic acid, glutamic pyruvic transaminases.</article-title> <source><italic>Am. J. Clin. Pathol.</italic></source> <volume>28</volume> <fpage>56</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1093/ajcp/28.1.56</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname> <given-names>C.</given-names></name> <name><surname>Lemasters</surname> <given-names>J. J.</given-names></name> <name><surname>Jaeschke</surname> <given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity.</article-title> <source><italic>Toxicol. Appl. Pharmacol.</italic></source> <volume>246</volume> <fpage>8</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2010.04.015</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schnackenberg</surname> <given-names>L. K.</given-names></name> <name><surname>Chen</surname> <given-names>M.</given-names></name> <name><surname>Sun</surname> <given-names>J.</given-names></name> <name><surname>Holland</surname> <given-names>R. D.</given-names></name> <name><surname>Dragan</surname> <given-names>Y.</given-names></name> <name><surname>Tong</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Evaluation of trans-sulfuration pathways in multiple liver toxicity studies.</article-title> <source><italic>Toxicol. Appl. Pharmacol.</italic></source> <volume>235</volume> <fpage>25</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2008.11.015</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>R.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Tanaka</surname> <given-names>K. E.</given-names></name> <name><surname>Gaarde</surname> <given-names>W. A.</given-names></name> <name><surname>Czaja</surname> <given-names>M. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.</article-title> <source><italic>Hepatology</italic></source> <volume>49</volume> <fpage>87</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1002/hep.22578</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stephen</surname> <given-names>U. A.</given-names></name> <name><surname>Abiodun</surname> <given-names>F.</given-names></name> <name><surname>Osahon</surname> <given-names>A.</given-names></name> <name><surname>Ewaen</surname> <given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Phytochemical analysis and antibacterial activity of <italic>Khaya grandifoliola</italic> stem bark.</article-title> <source><italic>J. Biol. Sci.</italic></source> <volume>9</volume> <fpage>63</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.3923/jbs.2009.63.67</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname> <given-names>Y.</given-names></name> <name><surname>Sakamoto</surname> <given-names>A.</given-names></name> <name><surname>Inoue</surname> <given-names>T.</given-names></name> <name><surname>Kikuchi</surname> <given-names>T.</given-names></name> <name><surname>Kajimoto</surname> <given-names>T.</given-names></name> <name><surname>Muraoko</surname> <given-names>O.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Andirolides H-P from flower of andiroba (<italic>Carapa guianensis</italic>, (Meliaceae).</article-title> <source><italic>Tetrahedron</italic></source> <volume>68</volume> <fpage>3669</fpage>&#x2013;<lpage>3677</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2011.12.076</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname> <given-names>Y.</given-names></name> <name><surname>Yamada</surname> <given-names>T.</given-names></name> <name><surname>In</surname> <given-names>Y.</given-names></name> <name><surname>Muraoko</surname> <given-names>O.</given-names></name> <name><surname>Kajimoto</surname> <given-names>T.</given-names></name> <name><surname>Tanaka</surname> <given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Absolute stereostructure of Andirolides A-G from the flowers of <italic>Carapa guianensis</italic> (Meliaceae).</article-title> <source><italic>Tetrahedron</italic></source> <volume>67</volume> <fpage>782</fpage>&#x2013;<lpage>792</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2010.11.028</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tundis</surname> <given-names>R.</given-names></name> <name><surname>Loizzo</surname> <given-names>R. M.</given-names></name> <name><surname>Menichini</surname> <given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>An overview on chemical aspects and potential benefits of limonoids and their derivatives.</article-title> <source><italic>Crit. Rev. Food Sci. Nutr.</italic></source> <volume>54</volume> <fpage>225</fpage>&#x2013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2011.581400</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wancket</surname> <given-names>L. M.</given-names></name> <name><surname>Meng</surname> <given-names>X. M.</given-names></name> <name><surname>Rogers</surname> <given-names>L. K.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitogen-activated protein kinase phosphatase (Mkp)-1 protects mice against acetaminophen-induced hepatic injury.</article-title> <source><italic>Toxicol. Pathol.</italic></source> <volume>40</volume> <fpage>1095</fpage>&#x2013;<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1177/0192623312447551</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Regulation of innate immune response by MAP Kinase phosphatase-1.</article-title> <source><italic>Cell. Signal.</italic></source> <volume>19</volume> <fpage>1372</fpage>&#x2013;<lpage>1382</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2007.03.013</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>F.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Luo</surname> <given-names>L.</given-names></name> <name><surname>Xie</surname> <given-names>Y.</given-names></name> <name><surname>Zeng</surname> <given-names>M.</given-names></name> <name><surname>Wang</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Role of mitochondrial electron transport chain dysfunction in Cr(IV)-induced cytotoxicity in L-02 hepatocytes.</article-title> <source><italic>Cell. Physiol. Biochem.</italic></source> <volume>33</volume> <fpage>1013</fpage>&#x2013;<lpage>1025</lpage>. <pub-id pub-id-type="doi">10.1159/000358672</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>Y.</given-names></name> <name><surname>McGill</surname> <given-names>M. R.</given-names></name> <name><surname>Dorko</surname> <given-names>K.</given-names></name> <name><surname>Kumer</surname> <given-names>S. C.</given-names></name> <name><surname>Schimitt</surname> <given-names>T. M.</given-names></name> <name><surname>Forster</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Mechanisms of acetaminophen-induced cell death in primary human hepatocytes.</article-title> <source><italic>Toxicol. Appl. Pharmacol.</italic></source> <volume>279</volume> <fpage>266</fpage>&#x2013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2014.05.010</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname> <given-names>T.</given-names></name> <name><surname>Zhu</surname> <given-names>R.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Odeku</surname> <given-names>O. A.</given-names></name> <name><surname>Yang</surname> <given-names>S.</given-names></name> <name><surname>Liao</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Structure determination of grandifotane A from <italic>Khaya grandifoliola</italic> by NMR, X-ray diffraction, and ECD calculation.</article-title> <source><italic>Org. Lett.</italic></source> <volume>12</volume> <fpage>252</fpage>&#x2013;<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1021/ol902565s</pub-id></citation></ref>
</ref-list>
<glossary>
<title>Abbreviations</title>
<def-list id="DL1">
<def-item>
<term>AIF</term>
<def>
<p>apoptosis-inducing factor</p>
</def>
</def-item>
<def-item>
<term>ALT</term>
<def>
<p>alanine aminotransferase</p>
</def>
</def-item>
<def-item>
<term>APAP</term>
<def>
<p>acetaminophen</p>
</def>
</def-item>
<def-item>
<term>Bax</term>
<def>
<p>Bcl<sub>2</sub>-associated X protein</p>
</def>
</def-item>
<def-item>
<term>CAT</term>
<def>
<p>Catalase</p>
</def>
</def-item>
<def-item>
<term>CYP2E1</term>
<def>
<p>cytochrome P450 2E1</p>
</def>
</def-item>
<def-item>
<term>DILI</term>
<def>
<p>drug-induced liver injury</p>
</def>
</def-item>
<def-item>
<term>GSH</term>
<def>
<p>reduced glutathione</p>
</def>
</def-item>
<def-item>
<term>GST</term>
<def>
<p>glutathione-<italic>S</italic>-transferase</p>
</def>
</def-item>
<def-item>
<term>H<sub>2</sub>DCFDA</term>
<def>
<p>2&#x2032;-7&#x2032;-Dichloro-dihydrofluorescein diacetate</p>
</def>
</def-item>
<def-item>
<term>HPLC</term>
<def>
<p>high performance liquid chromatography</p>
</def>
</def-item>
<def-item>
<term>HRMS</term>
<def>
<p>high resolution mass spectrometry</p>
</def>
</def-item>
<def-item>
<term>JNK</term>
<def>
<p>c-Jun N-terminal Kinase</p>
</def>
</def-item>
<def-item>
<term>Keap-1</term>
<def>
<p>Kelch-like ECH-associated protein-1</p>
</def>
</def-item>
<def-item>
<term>KgF25</term>
<def>
<p>methylene chloride/methanol (75:25 v/v) fraction of <italic>K. grandifoliola</italic></p>
</def>
</def-item>
<def-item>
<term>KgF25sf</term>
<def>
<p>sub-fraction of KgF25</p>
</def>
</def-item>
<def-item>
<term>MAPK</term>
<def>
<p>mitogen-activated protein kinase</p>
</def>
</def-item>
<def-item>
<term>MAT1A</term>
<def>
<p>methionine adenosyltransferase-1A</p>
</def>
</def-item>
<def-item>
<term>Mkp-1</term>
<def>
<p>mitogen-activated protein kinase phosphatase-1</p>
</def>
</def-item>
<def-item>
<term>NAPQI</term>
<def>
<p><italic>N</italic>-acetyl-para benzo-quinone imine</p>
</def>
</def-item>
<def-item>
<term>NMR</term>
<def>
<p>nuclear magnetic resonance</p>
</def>
</def-item>
<def-item>
<term>Nrf2</term>
<def>
<p>nuclear factor erythroid 2-related factor 2, p-JNK: Phospho-JNK</p>
</def>
</def-item>
<def-item>
<term>ROS</term>
<def>
<p>reactive oxygen species</p>
</def>
</def-item>
<def-item>
<term>SOD1</term>
<def>
<p>superoxide dismutase-1</p>
</def>
</def-item>
<def-item>
<term>SP</term>
<def>
<p>JNK inhibitor SP600125</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>